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General Introduction and outline of the Thesis
General Introduction 
The scientific journey travelled in this work started by studying Buruli Ulcer (BU) in the West 
African country Ghana. Ghana has a population of 27 million people. It is bordered by Togo to the 
east, Cote d’Ivoire to the west, Burkina Faso to the north and the Gulf of Guinea and the Atlantic 
Ocean to the south.
BU is a neglected tropical disease that affects the skin and subcutaneous tissue. In Ghana as well 
as in other West African countries, BU is a common cause of ulcerative lesions or wounds. BU 
is caused by a specific bacterium, Mycobacterium ulcerans, which secretes a toxin causing the 
tissue damage that results in the typical wounds observed in these patients. These wounds heal 
very slowly, and the potential impact of colonization by  other pathogenic bacteria, such as 
Staphylococcus aureus, and subsequent secondary infection of these wounds has emerged as an 
intriguing question. Indeed, many wounds, irrespective of their initial cause, e.g., burn wounds, 
may become colonized and infected by microorganisms that are either carried by the patient, 
acquired from the environment, or perhaps, transmitted by health care workers during wound 
care.
Dr Albert Cook, a British missionary doctor working at the end of the 19th century in the Mengu 
hospital in Kampala, Uganda, described the first cases of BU in Africa (1). He observed lesions 
that developed into large wounds or ulcers in patients who did not seem to experience much 
pain, and these patients neither had fever nor other symptoms of systemic disease. The wounds 
however failed to heal. In the 1960ies, in Buruli county, near the Nile river in Uganda, a place 
now known as Nakasongola, British Medical Research Council researchers reported and studied 
patients with the same ulcers previously described by Albert Cook, which thereafter became 
generally known as BU (2, 3). Several different explanations have been proposed for the slow 
progressive nature of BU and its extremely slow tendency to heal. Secondary infection is one of 
the possible explanations (4, 5).
Burns are common in low- and middle income countries where they are associated with high 
morbidity and mortality, much more so than in industrialized countries (6). Like BU, large burn 
wounds are prone to secondary infections, especially in case of limited health care resources and 
lack of infection control practices. Research on the prevention of colonization and secondary 
infections of these wounds is therefore urgently needed to improve patient care in the less 
affluent parts of the world.
Buruli ulcer
M. ulcerans infections  leading to  BU have been  reported  globally in  33  countries (7).
However, the highest burden of this disease occurs in sub-Saharan Africa including Benin, 
Cameroon, Cote d’Ivoire, the Democratic Republic of the Congo and Ghana (8). BU usually starts 
with an estimated incubation period of 34 days to several months with clinical presentation in the 
form of a nodule, a plaque or an edema (Figure 1A) (9). Subsequently, the skin may break down 
after destruction of the subcutaneous tissue leading to the development of large necrotic ulcers 
with undermined edges (Figure 1B) (10). BU occurs frequently on the lower limbs (55%) and is 
classified into three  categories depending of the disease severity (categories: I ≤ 5 cm, II 5 – 15 cm 
and III ≥ 15 cm or at critical sites such as the eye and genitals) (11, 12). The pathogenesis of BU is
1
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associated with the toxin mycolactone, which causes tissue necrosis and has immunosuppressive 
effects (13, 14).
The current regimen for treatment of BU is antibiotic therapy with streptomycin and rifampicin 
for two months  (12). Additionally, other antibiotics are frequently prescribed to treat suspected 
secondary infections or as extended prophylaxis after surgery (4). Unfortunately, guidelines 
on wound care including wound assessment and infection control as stipulated by the World 
Health Organization (WHO) are often insufficiently implemented by health care centers in BU 
endemic communities due to inadequate training of health care personnel (15–17). This is further 
exacerbated by inconsistent supply of wound care materials (gloves, sterile dressings material, 
forceps and scissors) and basic amenities such as running water and electricity (15). Consequently, 
these conditions predispose the wounds of BU patients to colonization and possibly infection  by 
other microorganisms (4, 5, 18). Hence, small lesions that are expected to heal within two to four 
weeks of antibiotic therapy and wound management usually take longer time to heal; even small 
lesions (< 10 cm) take a median time of 18 weeks to heal (19).
A.
B.
Figure 1. Clinical presentations of Buruli ulcer in the form of (A.) edema, and (B.) an ulcer.
Chapter 1
514537-L-bw-Amissah
Processed on: 17-10-2017 PDF page: 11
11  
Burn wounds
The human skin serves as a primary barrier to the external environment. Its damage due  to 
thermal burns disrupts the innate immune system and increases the chances for bacterial 
colonization and infection (20). Burns from fire and scalds account for approximately 33-59% of 
all reported burns in Africa (21). While the incidence of morbidities and mortalities from these 
injuries are decreasing in high-income countries, the reverse happens in low-income countries. 
Limited financial resources, inaccessible health care facilities and lack of trained professionals 
continue to hamper the management of burns in Africa, leading to high mortality rates ranging 
from 9% up to 27%. In Ghana, the mortality following flame burns (19%) was found to be higher 
than the mortality due to scald burns (13%) (22).
Infection in burns
It is estimated that about 25-31% of deaths by burns are due to infections (23, 24). Mortality 
depends on the severity of burns as described by the percentage of total body surface area 
(TBSA) that is affected. In sub-Saharan Africa, burn injuries occur frequently and the mortality 
rates are higher than in high-income countries. The latter can be concluded from the size of 
burns that cause 50% mortality, which is also referred to as the lethal dose of burn injury where 
50% of the burn patients die (LD50). In affluent industrialised countries the percentage of TBSA 
at which LD50 occurs is 77-99%, while this is 19-39% for burn injury victims in sub-Saharan 
Africa (25–31). Burns are common in Ghana and their treatment is complicated by unhygienic 
conditions, lack of adherence to infection control practices, malnutrition, and high antibiotics 
consumption leading to bacterial drug resistance and extended hospital stay (32, 33). Bacterial 
colonization precedes infection with 81-90% of patients being colonized by the end of the first 
week  of admission (34–36). The bacterial load and pathogenic potential of the microorganisms 
in burns do influence the rate of wound healing and the frequency of invasive infections (37). The 
organisms involved in these infections are often of an exogenous origin. They may be acquired 
by the patients, for example, through hospital equipment and supplies, catheters, air and cross 
transmission and outbreaks affecting other patients and healthcare workers. As a consequence, 
burn wound patients often die due to bacteremia and multiple organ failure (38–41). S. aureus, 
Klebsiella sp., Pseudomonas aeruginosa and Acinetobacter baumannii are reported as the common 
wound-colonizing and infecting organisms in the burn units (30, 42, 43).
S. aureus colonization in patients with Buruli ulcer and burn wounds
S. aureus is asymptomatically carried by about 20-30% of the general population. However, 
upon breaching the barriers imposed by the skin, mucosa and immune defenses, this bacterium 
can cause a wide range of infections, such as boils, abscesses, pneumonia, bacteremia and 
endocarditis (44–47). It is therefore not surprising that nasal colonization with S. aureus was 
shown to be a significant risk factor for the development of autologous wound infections (48, 
49), and that this pathogen is associated with  delayed wound healing and extended hospital 
stays at burn centers (50). Interestingly, S. aureus has fulfilled a central and driving role in the 
discovery and further development of antibiotics. Already in 1929, during experiments with S. 
aureus, Alexander Fleming observed that his culture plates were contaminated by the mold 
General Introduction and outline of the Thesis
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Penicillium notatum, and that the growth of S. aureus was inhibited in a zone around colonies 
of the mold. This observation led to the discovery of the antibiotic penicillin, a discovery that 
would profoundly change medicine. During World War II, penicillin has saved many lives of 
war trauma victims whose wounds had become infected by staphylococci and streptococci. 
However, S. aureus soon developed resistance to penicillin and, today, only a minority of the S. 
aureus isolates around the world are still susceptible to penicillin. Unfortunately, the same applied 
to many different antibiotics that were subsequently developed, including drugs like methicillin 
that at one stage were considered very effective in the fight against S. aureus infections. This is 
the reason why today multi-drug resistant variants of the so-called methicillin-resistant S. aureus 
(MRSA) dominate in many countries.
Outline of the Thesis
The overarching objective of the research described in this thesis was to investigate the bacterial 
colonization of BU and burn wounds in Ghana with a special focus on S. aureus. To this end, 
several specific research questions were addressed.
How diverse are the S. aureus isolates from Ghanaian BU patients?
At the start of this PhD research project, bacterial contamination and colonization of the ulcers 
in BU was suspected to be common and potentially contributing to morbidity (51, 52). The 
research described in Chapter 2 of this thesis was therefore aimed at investigating the diversity 
and topography of S. aureus colonizing BU patients during treatment at a healthcare center in 
Ghana. In brief, the results showed that the wounds of many BU patients were contaminated with 
S. aureus. Also, many BU patients from different communities carried the same S. aureus genotype 
during treatment, which was indicative of transmission events.
Is S. aureus transmitted during wound care of BU patients in health care centers? What are the 
implications?
Infection control during wound care is important in preventing transmission of potential 
pathogens. However, hospital protocols on infection control are lacking in many health care 
centers of BU endemic communities (15). This is an important issue since several S. aureus clones 
that are multi-resistant to commonly prescribed antibiotics have been reported in health care 
institutions in Ghana with the S. aureus sequence types (ST) 15, 121 and 152 being the most 
prevalent (53). BU patients may therefore be at risk of hospital-associated colonization with multi-
drug resistant S. aureus due to their frequent visits to health care centers for wound care. The 
research described in Chapter 3 was thus aimed at investigating possible S. aureus transmission 
events among BU patients using different molecular typing methods. Indeed, whole-genome 
sequencing data confirmed transmission of MRSA and methicillin susceptible S. aureus among 
patients that probably took place during wound care. Further, this analysis allowed a detailed 
dissection of the antibiotic resistances of the investigated S. aureus isolates, leading to the 
identification of a novel allele of the fexB gene conferring chloramphenicol resistance.
Chapter 1
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Do S. aureus virulence factors potentially contribute to delayed wound healing in BU?
Although M. ulcerans is effectively killed during antibiotic therapy, colonization of BU wounds 
with other microorganism, such as S. aureus, may account for the long duration of wound healing 
(19). This idea is based on the fact that S. aureus can produce a range of virulence factors with 
known involvement in the persistence of colonization, infection, tissue damage and delayed 
wound healing (54). The research described in Chapter 4 was therefore aimed at creating a first 
compendium of the virulence factors potentially produced by S. aureus isolates from BU patients. 
The results show that such virulence factors include, for example, notorious toxins such as 
hemolysins, Panton-Valentine leucocidin (PVL) and phenol soluble modulins.
How does S. aureus behave in wounds of Ghanaian patients with severe burns?
Colonization and infection of burn wounds with S. aureus can lead to wound sepsis and bacteremia 
(55, 56). In Ghana, the cost of microbiological diagnostics is not affordable to most burn victims. 
Hence, infections that lead to preventable deaths often occur in such patients (57). Chapter 5 
describes the prevalence and antibiotic resistance of S. aureus isolates from burn wound patients 
and the health care workers who treated them over time. The study further reports on the 
antibiotics prescription behavior that may add to  the current burden of antimicrobial resistance.
Is MRSA surveillance in burn units of Ghanaian hospitals necessary? 
Nosocomial wound infections are commonly observed in healthcare settings in Ghana (58, 
59). Chapter 6 reports on the S. aureus populations circulating in a Ghanaian burn unit, and the 
possible transmission of MRSA between patients and health care workers. Indeed, the results of 
this study provide compelling evidence for MRSA transmission events and unnoticed outbreaks. 
They thus focus attention on the need for stricter compliance to hand hygiene and other infection 
preventive measures.
Chapter 7 summarizes the results described in this thesis, and Chapter 8 places the research 
contained in this thesis in a broader context with future perspectives.
General Introduction and outline of the Thesis
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Buruli ulcer (BU) is a necrotizing skin disease caused by Mycobacterium ulcerans. Previous studies 
have shown that wounds of BU patients are colonized with M. ulcerans and several other 
microorganisms, including Staphylococcus aureus, which may interfere with wound healing. The 
present study was therefore aimed at investigating the diversity and topography of S. aureus 
colonizing BU patients during treatment.
Methodology
We investigated the presence, diversity, and spatio-temporal distribution of S. aureus in 30 
confirmed BU patients from Ghana during treatment. S. aureus was isolated from nose and wound 
swabs, and by replica plating of wound dressings collected bi-weekly from patients. S. aureus 
isolates were characterized by multiple-locus variable number tandem repeat fingerprinting 
(MLVF) and spa-typing, and antibiotic susceptibility was tested.
Principal Findings 
Nineteen (63%) of the 30 BU patients tested positive for S. aureus at least once during the sampling 
period, yielding 407 S. aureus isolates. Detailed analysis of 91 isolates grouped these isolates into 
13 MLVF clusters and 13 spa-types. Five (26%) S. aureus-positive BU patients carried the same 
S. aureus genotype in their anterior nares and wounds. S. aureus isolates from the wounds of 
seven (37%) patients were distributed over two different MLVF clusters. Wounds of three (16%) 
patients were colonized with isolates belonging to two different genotypes at the same time, and 
five (26%) patients were colonized with different S. aureus types over time. Five (17%) of the 30 
included BU patients tested positive for methicillin-resistant S. aureus (MRSA). 
Conclusion/Significance
The present study showed that the wounds of many BU patients were  contaminated  with S. 
aureus, and that many BU patients from he different communities carried the same S. aureus 
genotype during treatment. This calls for improved wound care and hygiene.
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Genetic Diversity of Staphylococcus aureus in Buruli ulcer
Introduction
Buruli ulcer (BU) is a neglected necrotizing skin disease caused by Mycobacterium ulcerans, 
emerging mainly in West Africa with Benin, Côte d’Ivoire and Ghana bearing the highest burden 
of disease [1]. The disease usually starts as a painless nodule, plaque, oedema or papule and 
progresses to form large ulcers when left untreated. The pathology of BU is strongly associated 
with the production of mycolactone [2], an immunomodulatory macrolide toxin that causes tissue 
necrosis [3]. The regimen for treatment of BU disease is streptomycin and rifampicin for 2 months 
[4–6]. Wound care is an important aspect of treatment but frequently facilities and knowledge 
on appropriate wound care are missing [7]. BU often results in disfiguring complications, such 
as contractures and sometimes amputations. More than half of the patients have permanent 
limitations in the performance of daily activities due to seeking treatment at a later stage [8,9]. 
Wounds of most BU patients are colonized with several other microorganisms in addition to M. 
ulcerans [10,11]. Although risk factors for bacterial wound colonization have not been thoroughly 
studied to date, delayed treatment and insufficient wound management might contribute to 
colonization and prolonged wound healing. Until now there are only two studies that describe 
the microorganisms colonizing the wounds of BU patients cultured from superficial swabs, 
indicating the presence of Pseudomonas aeruginosa, Proteus mirabilis, Enterobacteriaceae, Group 
A, B and C Streptococcus, and Staphylococcus spp., including Staphylococcus epidermidis and 
Staphylococcus aureus. Notably, between 33% [11] and 38% [10] of the detected S. aureus isolates 
were methicillin-resistant S. aureus (MRSA).
S. aureus is usually a harmless commensal, carried by about 20-30% of the general population 
[12,13]. However, it can transform into a dangerous pathogen causing a wide range of infections 
in both community and hospital settings. These infectious diseases range from relatively mild 
skin infections, such as boils and abscesses, to life-threatening conditions such as pneumonia, 
bacteremia and endocarditis [14,15]. Nasal colonization with S. aureus has been associated with 
delayed wound healing and prolonged length of stay at burn centres [16] and previous studies 
have shown a significant risk for the development of autologous wound infections by nasal 
carriers [17,18]. In BU patients, mycolactone production limits the primary immune responses 
and recruitment of inflammatory cells to the site of infection. The mycolactone can thus act as an 
immunosuppressive agent [19] that predisposes wounds to bacterial colonization and infections.
In this study, we aimed at investigating the diversity and topography of S. aureus colonizing BU 
patients from Ghana during treatment. S. aureus isolates cultured from nose and wound swabs, 
as well as wound dressings were typed by multiple-locus variable number tandem repeat 
fingerprinting (MLVF) and spa-typing. Our results show that wounds of three (16%) S. aureus-
carrying BU patients were colonized with two different genotypes of S. aureus, which were 
sometimes found in close proximity to each other. Importantly, 28 (31%) isolates from patients, 
who came from different communities but visited the same health centre for treatment, were 
grouped into the same MLVF clusters and harboured related spa-types, showing the high genetic 
relatedness of S. aureus isolates colonizing BU patients.
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Materials and Methods 
Ethical approval
The ethical committee of the Noguchi Memorial Institute for Medical Research (NMIMR) (FEDERAL 
WIDE ASSURANCE  FWA  00001824) approved the use of clinical samples for this investigation. 
Samples were collected upon written informed consent from all patients.
Confirmation of BU cases
Sampling was done at the Pakro Health Centre, in the Eastern region of Ghana. Patients with 
suspected BU from different communities reported to the health centre for  diagnosis. Using the 
BU 01.N form (www.who.int/buruli/control/ENG_BU_01_N), information such as the age, place of 
residence, size of lesion (categories: I ≤ 5 cm, II 5- 15 cm and III ≥ 15 cm or at critical sites such as 
the eye and genitals) was obtained  before sampling for diagnosis. For the diagnosis of BU, wound 
swabs from ulcers were collected from patients and kept in 15 ml Falcon tubes containing 2 ml 
transport medium (Middlebrook 7H9 supplemented with polymyxin, amphotericin B, nalidixic 
acid, trimethoprim and azlocillin [PANTA]). DNA was extracted from the samples using the 
modified Boom method [20]. IS2404 nested PCR was performed as described previously [21]. 
Patients whose samples tested positive for the presence of the IS2404 target were confirmed 
to have BU. Patients visited the health centre daily for antibiotic therapy with rifampicin and 
streptomycin for two months, and wound management twice a week until their wounds healed.
Cultivation of S. aureus
Nose and wound swabs of 30 PCR-confirmed BU patients were collected bi-weekly from December 
2012 until July 2013 (sampling time points designated as: t1 to t13) or until their wounds healed. 
The patient material was transported to the NMIMR the same day for culture. Swabs were streaked 
on cysteine lactose electrolyte-deficient (CLED) agar and incubated at 37°C for ~24 h. S. aureus 
was subcultured on blood agar (BA) plates containing 5% sheep blood and incubated overnight 
at 37°C. In addition, wound  dressings that had covered the wounds of patients for a maximum of 
three days were collected. The topography of S. aureus in the wounds was determined by replica 
plating the wound dressing on CLED agar and incubation of the plates at 37°C for ~24 h. Initially, 
between 50 and 82 potential S. aureus colonies per patient were selected from the wound replica 
plates and subcultured on CLED agar until colonies were pure. This number was later reduced to 
2 to 10 colonies per patient; the respective colonies were selected based on morphology, size 
and color/pigmentation. In comparison with our initial sample size, this convenience sample was 
sufficient to pick up >95% of the S. aureus types present in each lesion. Identification of S. aureus 
was confirmed using the Pastorex Staph Plus test (Bio-Rad, Marnes-la-Coquette, France). S. aureus 
isolates were subsequently transported to the University Medical Center Groningen (UMCG) on 
tryptic soy agar containing 5% sheep blood, subcultured on BA, and stored in 17% glycerol at - 
80°C for further analyses.
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Identification of other microorganisms in the wounds of BU patients 
Colonies from the replica plates that did not phenotypically resemble S. aureus were identified 
using   matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF 
MS) with a microflex LT Biotyper (Bruker Daltonics, Bremen, Germany) according to manufacturer’s 
instructions. Briefly, different colonies were applied onto the MALDI-TOF MS target and overlaid 
with 1 µl matrix solution, which is a saturated solution of α-cyano-4-hydroxycinnamic acid in 50% 
acetonitrile and 2.5% trifluoroacetic acid. The target was then air-dried at room temperature and 
analyzed in the Biotyper. A log score is calculated by the Biotyper software by comparing data 
of the unknown organism with data of reference organisms for identification of the  unknown 
organism (log score ≥ 2 – reliable species identification (ID); log score > 1.7 < 2 reliable genus ID; 
log score < 1.7 no reliable ID).
DNA extraction
Total DNA was prepared from S. aureus colonies taken from BA plates as described by Glasner et al. 
[22]. Briefly, 2 to 3 colonies were resuspended in 500 μl of Tris-EDTA  (TE) buffer (pH 8.0) containing 
zirconia/silica beads with a diameter of 100 µm in 1.5 ml bead-beating tubes with screw caps. The 
cells were disrupted using a Precellys bead beater (Bertin Technologies, Saint Quentin en Yvelines, 
France) in 3 pulses of 30 s at a speed of 5,000 rpm with 30 s intervals between the pulses. Samples 
were subsequently heated to 95°C for 10 min and centrifuged (14,000 rpm) at 4°C for 10 min. A 
volume of 200 µl of the resulting supernatant fraction was transferred into a fresh tube and stored 
at -20°C until further use.
Detection of the accessory gene regulator, mecA and Panton-Valentine leukocidin genes 
All S. aureus isolates were screened for the presence of the mecA, accessory gene regulator (agr) 
(types I, II, III and IV) and Panton-Valentine leukocidin (PVL) (lukS- PV/lukF-PV) genes by PCR as 
described previously [23–26].
MLVF
MLVF was performed using a modified protocol as described by Glasner et al. [22] and Sabat et al. 
[27]. Briefly, 1 µl of genomic DNA was subjected to a multiplex PCR targeting seven staphylococcal 
genes (sdrC, sdrD, sdrE, clfA, clfB, sspA and spa). The resulting PCR products were first separated 
on 2% agarose gels, because this is most economic. Subsequently, MLVF samples from S. aureus 
isolates with clearly different MLVF banding patterns, or the same MLVF banding patterns but 
different agr, mecA and PVL profiles were further analyzed with microfluidic DNA 7500 chips using 
the Bioanalyzer 2100 (Agilent Technologies, Palo Alto, USA). Notably, these chips have a higher 
resolution than agarose gels, and the recorded electropherograms can be used for automated 
data processing. To this end, 1 µl of each PCR reaction was loaded onto a DNA 7500 chip. Next, the 
PCR-amplified DNA fragments were separated by electrophoresis and electropherograms were 
automatically recorded according to the manufacturer’s instructions. In each Bioanalyzer run, the 
clinical S. aureus isolate M2, isolated at the UMCG [27] was added as a technical control to ensure 
the reproducibility of the generated data. The data generated with the Bioanalyzer were imported 
as CSV files into the GelCompar II software (Applied Maths, Kortrijk, Belgium) for analysis.
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The position tolerance and optimization were set at 0.9% and 0.5% respectively. Using the 
selected position tolerance, the M2 control isolate for all Bioanalyzer runs showed identical MLVF 
banding patterns. Pairwise similarity coefficients were calculated using the dice formula and the 
dendrogram was generated using the unweighted pair group method using average linkages 
(UPGMA). Identical patterns were designated as the same MLVF subtype. After visual inspection 
of the MLVF dendrogram, six different cut-off values (66%, 77%, 79%, 81%, 82% and 84%) were 
chosen for testing the concordance between MLVF and spa-typing. The concordance between 
the two DNA typing methods was calculated with the Ridom EpiCompare software version 1.0 
as described previously [27]. The cut-off value with the highest concordance between the two 
typing methods  was used for clustering of the MLVF patterns.
Spa-typing
Spa-typing of the 91 S. aureus isolates was performed as previously described by Harmsen et al. 
[28]. DNA sequences were obtained using an ABI Prism 3130 genetic analyser (Applied Biosystems, 
Foster City, USA). Spa-types were determined using the Ridom Staph Type software version 2.2.1 
(Ridom GmbH, Würzburg, Germany) [28].  The spa-types were grouped into spa-clonal complexes 
(spa-CCs) with the based upon  the repeat pattern (BURP) algorithm utilizing the Ridom Staph 
Type software. Spa-types shorter than 4 repeats were excluded from the analysis, and spa-types 
were clustered if the costs were ≤ 4.
Antibiotic susceptibility testing
Antibiotic susceptibility was determined with the VITEK 2 system (AST-P633, bioMerieux 
Corporate, Marcy l’Etoile, France) according to the manufacturer’s instructions. The used card 
contained the following antibiotics:  benzylpenicillin, cefoxitin, chloramphenicol, ciprofloxacin, 
clindamycin, erythromycin, fosfomycin, fusidic acid, gentamicin, kanamycin, linezolid, mupirocin, 
oxacillin, rifampicin, teicoplanin, tetracycline, tobramycin, trimethoprim/sulfamethoxazole and 
vancomycin. The VITEK 2 minimum inhibitory concentration (MIC) results were interpreted using 
the Advanced Expert System following EUCAST guidelines (www.eucast.org).
Results
Thirty of 60 patients receiving treatment at the Pakro Health Centre were confirmed with BU 
during the time of investigation. These patients had a median age of 44 years, and presented the 
three disease categories as follows: 30% presented category I lesions, 46.7% category II lesions 
and 23.3% category III lesions. Clinical signs such as excessive inflammation, exudates and severe 
pain in the first month of the antimicrobial therapy were observed for the wounds of, respectively, 
one (3%), two (7%), and 15 (50%) of the 30 BU patients. Samples from 19 (63.3%) of these patients 
tested positive for S. aureus at least once. These 19 patients came from 14 different communities 
in Ghana (Fig. 1). S1 Fig. displays the frequency of S. aureus isolation from the 19 BU patients at 
different  time points (marked t1 to t13). Specifically, S. aureus was cultured at least once from the 
nasal swabs from seven (37%) of these 19 patients, wound swabs from ten (53%) patients and 
wound dressings from 15 (79%) patients.
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Figure 1. Map of Ghana indicating the region and communities from which the 19 BU patients colonized with S. 
aureus originated.
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Time point of 
sampling 
spa-type spa repeats No. of isolates 
2 t2, t3, t8, t9 t786 07-12-21-17-13-34-34-33-34 8 
3 t2, t7, t8, t9, t10, t11 t084 07-23-12-34-34-12-12-23-02-12-23 8 
 t8 t355 07-56-12-17-16-16-33-31-57-12 2 
 t9 t314 08-17-23-18-17 2 
4 t7 t084 07-23-12-34-34-12-12-23-02-12-23 1 
5 t11 t355 07-56-12-17-16-16-33-31-57-12 2 
6 t1 t7835 07-82-21-17-34-34-16-34-33-13 2 









 t8 t1096 07-56-17-16-16-33-31-57-12 1 
 t6, t8, t939 04-16-34-12-34-12 2 
 t6, t8, t11 t084 07-23-12-34-34-12-12-23-02-12-23 10 
 t11 t002 26-23-17-34-17-20-17-12-17-16 1 
10 t2, t3, t4, t5, t8 t355 07-56-12-17-16-16-33-31-57-12 12 
11 t2, t5 t355 07-56-12-17-16-16-33-31-57-12 2 
12 t8, t13 t314 08-17-23-18-17 2 
 t13 t12836 08-13-13-17-34-16-34 1 
13 t1 t186 07-12-21-17-13-13-34-34-33-34 1 
17 t2 t346 07-23-12-34-12-12-23-02-12-23 1 
 t2, t4 t11375 07-56-12 4 
18 t5 t355 07-56-12-17-16-16-33-31-57-12 1 
19 t3 t786 07-12-21-17-13-34-34-33-34 1 
21 t7 t084 07-23-12-34-34-12-12-23-02-12-23 1 
22 t4 t2724 26-17-34-20-17-12-17-16 1 
 t6, t8, t9, t12 t084 07-23-12-34-34-12-12-23-02-12-23 5 
 t6, t9 t314 08-17-23-18-17 4 
 t6, t8, t9, t12 t939 04-16-34-12-34-12 4 
24 t5 t355 07-56-12-17-16-16-33-31-57-12 1 
26 t9 t084 07-23-12-34-34-12-12-23-02-12-23 1 
 t9 t314 08-17-23-18-17 1 
27 t11 t084 07-23-12-34-34-12-12-23-02-12-23 1 
30 t12 t084 07-23-12-34-34-12-12-23-02-12-23 1 
	
Table 1. spa-types of 91 S. aureus isolates from the anterior nares and wounds of 19 BU patients
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MLVF
The S. aureus isolates from the different patient samples were typed by MLVF. Altogether, this 
involved 407 S. aureus isolates from 19 patients. The respective MLVF banding patterns were 
initially analyzed on agarose gels. Subsequently, 91 S. aureus isolates with clearly different 
MLVF banding patterns, or the same MLVF banding patterns but different agr, mecA and PVL 
profiles were selected for a further characterization with microfluidic DNA 7500 chips using the 
Bioanalyzer 2100. The Bioanalyzer data were then used to generate the dendrogram shown in Fig. 
2. Altogether, the MLVF analysis resulted in 24 different banding patterns, of which ten patterns 
were represented by two or more isolates and 14 patterns by a single isolate. The application of 
the different cut-off values (66%, 77%, 79%, 81%, 82% and 84%) with the subsequent analyses of 
the concordance with the identified spa-types resulted in Adjusted Rand’s coefficients of 0.952, 
0.973, 0.979, 0.980, 0.938 and 0.907, respectively. The cut-off value of 81% yielded the highest 
concordance (0.980) resulting in 13 clusters of which eight comprised two or more isolates. These 
13 clusters were denoted as A (n = 28), B (n = 1), C (n = 1), D (n = 2), E (n = 4), F (n = 25), G (n = 2), 
H (n = 10), I  (n = 1), J (n = 1), K (n = 1), L (n = 9) and M (n = 6). The two major clusters A and F were 
composed of 28 and 25 isolates respectively, and they were derived from eight patients each (Fig. 
2, S1 Table). The clusters A, D, F and G included two or more isolates from the anterior nares and 
the wounds of individuals patients (five [26%] of 19 BU patients), suggesting autoinoculation from 
the nose to the wound, or vice versa. Furthermore, both clusters H and L include isolates from the 
wounds of different patients, which is indicative for transmission events between patients. This 
may also be the case for the MLVF cluster M, which comprised six isolates from the anterior nares 
of two patients that were not detected in their wounds or wound dressings (Fig. 2, S1 Table).
Genetic Diversity of Staphylococcus aureus in Buruli ulcer
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Figure 2. MLVF dendrogram of 91 S. aureus isolates from BU patients.
The dendrogram was generated using the UPGMA algorithm. Additionally, seven technical controls designated 
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Table 2. Antibiotic resistances of the 91 S. aureus study isolates. 
 
Antibiotic No. (resistance rate %) 
Ciprofloxacin 2 (2.2) 
Chloramphenicol 59 (64.8) 
Clindamycin (constitutive) 0 (0) 
Erythromycin 2 (2.2) 
Fosfomycin 1 (1.1) 
Fusidic Acid 0 (0) 
Gentamicin 0 (0) 
Kanamycin 0 (0) 
Linezolid 0 (0) 
Mupirocin 0 (0) 
Oxacillin 12 (13.1) 
Penicillin 90 (98.9) 
Rifampicin 7 (7.7) 
Teicoplanin 1 (1.1) 
Tetracycline 70 (76.9) 
Tobramycin 0 (0) 
Trimethoprim/sulfamethoxazole 27 (29.7) 






Table 2. Antibiotic resistances of the 91 S. aureus study isolates
Spa-typing
The 91 isolates examined by MLVF on the Bioanalyzer were also characterized by spa-typing. This 
yielded 13 spa-types including one new spa-type (t12836). Specifically, the numbers of identified 
repeats ranged between 3 (t11375) and 11 (t084) (Table 1). Seven spa-types were represented by 
two or more isolates and six were represented by single isolates. BURP analysis resulted in no spa-
CCs in the present collection, but grouped 67 isolates (74% of all investigated isolates) in three 
groups with no founder  (Fig. 3). Twenty isolates (22% of all investigated isolates) comprising six 
spa-types (46% of all spa-types) were identified as singletons (Fig. 3), and four isolates (4% of all 
investigated isolates) comprising one spa-type (t11375, 8% of all spa-types) were excluded.
 
Genetic Diversity of Staphylococcus aureus in Buruli ulcer
2
514537-L-bw-Amissah
Processed on: 17-10-2017 PDF page: 28
 28 
Figure 3. Population structure of the 91 S. aureus isolates from BU patients.
The population structure was obtained by BURP analysis. In the present S. aureus collection, comprising 13 different 
spa-types no spa-CCs could be generated. The BURP analysis grouped isolates together into three groups with 
no founder, comprising 27 (30% of all isolate), 29 (32% of all isolate) and 11 (12% of all isolate) S. aureus isolates, 
respectively. Twenty isolates (22% of all isolates) comprising six spa-types (46% of all spa-types) were identified 
as singletons, and four isolates (4% of all isolates) comprising one spa-type (t11375, 8% of all spa-types) were 
excluded. The circle size is proportional to the number of isolates in each cluster.
Bacterial topography in wounds of BU patients
To determine the bacterial topography in the wounds of BU patients, used wound dressings were 
replica plated onto CLED agar plates. This led to the observation of either distinct colonies or 
confluent growth of S. aureus in combination with other microorganisms. Species identification 
with the microflex LT Biotyper revealed the presence of Acinetobacter baumannii, Corynebacterium 
striatum, Enterococcus casseliflavus, Enterococcus faecalis, Escherichia coli, Klebsiella pneumoniae, 
Pseudomonas aeruginosa, S. epidermidis, S. haemolyticus, and/or S. hominis in wound dressings from 
15 (79%) of the 19 included patients. In fact, highly heterogeneous bacterial wound populations 
made it impossible to detect S. aureus in the case of three BU patients. In the case of one patient 
(no. 30) no S. aureus was identified upon replica plating of the wound dressings, and the only S. 
aureus isolate of this patient was obtained at one time point from the anterior nares (Fig. 2).
The MLVF typing results of the 49 S. aureus isolates obtained from 15 (79%) of the 19 included 
patients through replica plating of wound dressings were distributed among five different 
clusters (A, D, F, H and L) (Fig. 2, S1 Table). In this case, the number of  isolates selected from a 
single patient varied from one to six. Interestingly, four of the  five clusters, namely A (n = 7), F (n 
= 7), H (n = 3) and L (n = 4), harboured isolates  from patients who reside in different communities 
(Fig. 2, S1 Table). With regard to the identified S. aureus diversity over time in the wounds of the 15 
BU patients, different observations were made. In the case of 11 (73%) patients the same S. aureus 
isolates remained detectable over time. For example, patient 2 was colonized at four sampling 
time points with S. aureus isolates that belonged to cluster H, while patients 10 and 11 carried 
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isolates of cluster F for the entire duration of the study (Fig. 2, S1 Table). Three other patients 
carried S. aureus belonging to two MLVF clusters in one wound at one  time point. For example, 
this was the case for patient 22 who was colonized with isolates that grouped in clusters A and L 
at time point t6 (Fig. 4, S1 Table). For five (33%) patients a temporal change of S. aureus genotypes 
in their wounds was detected as judged by MLVF and spa-typing. For example, patient 3 was 
colonized with S. aureus isolates that belonged to cluster A at time t2, cluster F at t8, and cluster 
L at t9 (S1 Table). Furthermore, patient 12 was colonized with S. aureus of cluster L at t8, and at 
t13 with clusters C and L (S1 Table). Moreover, patient 7 was found to be colonized by S. aureus 
belonging to four MLVF clusters over time. This patient carried S. aureus of cluster F at t4, clusters 
F and H at t5, cluster A at t6, clusters A and D at t8, and cluster A at t11 (Fig. 4, S1 Table).
Figure 4. S. aureus wound topography in BU patients.
Used dressings from wounds of BU patients were replica-plated onto CLED agar plates, and S. aureus colonies thus 
obtained were typed by MLVF. S. aureus colonies belonging to different MLVF clusters are shown in different colors: 
cluster A, red circles; cluster D, blue circles; cluster F, yellow circles; cluster H, green circles and cluster L, purple circles. 
(A) Replica plate of a wound dressing collected from patient 7 at time point t8 with S. aureus colonies belonging to 
clusters A and D, (B) Replica plate of a wound dressing collected from patient 7 at time t5 with S. aureus colonies 
belonging to clusters F and H. (C) Replica plate of a wound dressing collected from patient 22 at time t6 with S. 
aureus colonies belonging to clusters A  and L.
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Antibiotic resistance pattern and detection of mecA, agr and PVL genes 
All 91 S. aureus isolates were tested for their antibiotic susceptibility and the results are presented 
in Table 2. All 91 isolates were found to be susceptible to clindamycin, fusidic acid, gentamicin, 
linezolid, mupirocin, tobramycin and vancomycin, while resistance to penicillin was observed 
in 90 isolates (99%) (S1 Table). Chloramphenicol resistance was observed for 59 (65%) isolates 
that belonged to the MLVF clusters A, F, G, H, J, L and M. Two isolates (2%) of clusters F and K 
were resistant to ciprofloxacin. Only one isolate that was grouped in cluster F was resistant to 
fosfomycin and teicoplanin and displayed an intermediate resistance phenotype to kanamycin. 
Seven (8%) isolates from the clusters A, F and L were resistant to rifampicin. The latter isolates were 
obtained  from 4 (21%) of the 19 S. aureus-positive patients; from three of these patients, rifampicin 
resistant isolates were obtained 1-5 months after therapy with rifampicin and streptomycin, while 
rifampicin resistant isolates from one patient were obtained two weeks before the end of the 
antibiotic therapy. Seventy (77%) isolates belonging to eight clusters (A, D, F, G, H, I, J and L) 
were resistant to tetracycline. Twenty-seven (30%) isolates belonging to clusters A, B, F, I and L 
were resistant to trimethoprim/sulfamethoxazole (S1 Table). Twelve (13%) isolates belonging to 
MLVF clusters F, H, J and K were resistant to cefoxitin and oxacillin, which implies that they  are 
MRSA. Nonetheless, one of these tested negative for the mecA and mecC genes, suggesting that 
an as yet unidentified determinant causes the cefoxitin and oxacillin resistance. Interestingly, in 
wounds of three of the five patients from which oxacillin resistant isolates belonging to MLVF 
clusters F and H were collected, we also identified methicillin-sensitive S. aureus (MSSA) of the 
same genotype (S1 Table).
Lastly, agr typing revealed the presence of all four agr types among this collection (type I: 28 
(31%) isolates, type II: 26 (29%) isolates, type III: 13 (14%) isolates, and type IV: 17 (19%) isolates). 
The six (7%) isolates that were grouped in cluster M tested negative for the agr gene, and for 
one isolate (1%) originating from cluster F no agr type could be determined as the obtained PCR 
product did not match with any of the known type- specific PCR products. Six patients were 
colonized with S. aureus isolates grouping into the same MLVF clusters, but belonging to different 
agr groups (S1 Table). Fifty-five (60%) of the 91 isolates obtained from 15 (79%) of the 19 patients 
over time tested positive for the PVL-encoding genes (S1 Table).
Discussion
In the present study, we have explored the diversity and topography of S. aureus in BU patients 
as well as the temporal changes in the population of this opportunistic pathogen during patient 
treatment. To investigate the spatio-temporal distribution of S. aureus, MLVF and spa-typing were 
used for the determination of their genotypes.
It has been reported previously that over 80% of the people with skin lesions are nasal S. aureus 
carriers [29,30]. Furthermore, van der Kooi-Pol et al. [31,32] reported that about 62-75% of the 
patients with the genetic blistering disease epidermolysis bullosa (EB) were colonized with S. 
aureus in the anterior nares, depending on the absence or presence of chronic wounds, and 
that 69-92% of these patients carried S. aureus in their wounds [32]. In ~60% of the investigated 
cases, EB patients carried the same type of  S. aureus in their upper respiratory tract and wounds 
suggesting a high frequency of auto-inoculation [31]. In the present study, 19 BU patients tested 
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positive for S. aureus at least once; 37% of these BU patients were found to contain S. aureus at 
least once in the anterior nares, 79% contained S. aureus in their wounds at any one point in time, 
and 26% contained S. aureus with the same genotype in their wounds and nose. Nasal carriage 
of S. aureus in the healthy human population varies between 12-30% [13,17]. It thus seems that 
the nasal S. aureus carriage rate in BU patients (23% of all 30 included patients) resembles that of 
the healthy population, and is much lower than in EB patients. On the other hand, the frequency 
of S. aureus wound colonization in all 30 included BU patients (50%) is slightly lower than that of 
EB patients, while the potential auto-inoculation between the nose and wounds of BU patients 
(26%) as evidenced by the detection of S. aureus  isolates with the same MLVF and spa-types at 
both body sites  appears  substantially lower than observed for EB patients. These differences may 
relate to the fact that EB patients suffer from recurring wounds right from the moment of birth, 
while BU patients develop wounds only upon infection with M. ulcerans. Accordingly, EB patients 
are likely to be exposed to S. aureus for much longer periods of time than BU patients.
Our present typing analyses show that 98% of the isolates from BU patients that group in the same 
MLVF cluster have the same spa-type (Fig. 2). Only cluster D contained two isolates with different 
and unrelated spa-types, namely t355 and t1096. Within the collection of the 91 investigated 
isolates, most isolates (58%) were grouped in the MLVF clusters A and F with the respective spa-
types t084 and t355. In a recent study, these spa-types have been reported as the most prevalent 
types in healthcare institutions in Ghana [33].  Notably,  the  wounds  of  the  majority  of  patients 
followed over time were continuously colonized with the same S. aureus MLVF type, and only 
seven BU patients carried S. aureus isolates belonging to different unrelated types. Contrary 
to these findings, highly variable S. aureus types have been isolated from EB and cystic fibrosis 
patients [34,35]. Moreover, the genotypes of patient isolates identified in the present study were 
not specific for particular patients. Instead, we frequently found that different BU patients carried 
S. aureus with the same MLVF and spa-types at the same or successive time points (S1 Table). This 
suggests possible patient transmission events. Since the studied BU patient cohort is composed 
of patients who all visited the Pakro Health Centre at the same time for antibiotic therapy and 
wound care treatment, it is conceivable that (indirect) patient-to-patient transmission of S. aureus 
has occurred during this event. This view would be consistent with the finding that spa-types t084 
and t355 are dominant in healthcare settings in Ghana [33]. On the other hand, we cannot rule out 
the possibility that transmission events may have occurred in the communities. For the present 
study we were, unfortunately, unable to obtain samples from the cleansing solutions, surfaces of 
dressing equipment and the healthcare workers who dressed the wounds of the patients. Samples 
from the household members of the investigated BU patients could have further informed us on 
how S. aureus and other detected wound- colonizing bacteria are potentially transmitted from 
family members to patients (i.e. during wound dressing) and subsequently via the healthcare 
setting to other patients.  Lack of information on these potential sources makes it difficult to 
infer the exact source from which these patients were colonized with any certainty. Although 
the evidence for inter-patient S. aureus transmission events that we present here is strong, to 
obtain final proof for the idea that the S. aureus isolates with identical  MLVF and spa-types from 
different patients reflect transmission events, it will be necessary to analyze these isolates by a 
more discriminatory typing method such as whole-genome sequencing (WGS). Data generated 
Genetic Diversity of Staphylococcus aureus in Buruli ulcer
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by WGS provide a much higher resolution in the investigation of transmission events than any of 
the more conventional typing methods [36–38].
The analysis of the bacterial topography of the wounds of BU patients showed that wound-
colonizing S. aureus isolates belonged to the same or two different MLVF  clusters at particular 
time points. A similar investigation on chronic wounds of EB patients also showed the co-
existence of distinct S. aureus types in close proximity, although in this case the co-existence of up 
to six distinct S. aureus types was observed [35]. Furthermore, our present analysis of the bacterial 
wound topography of BU patients over time showed that the population of S. aureus may shift 
(Fig. 2, Table 1). This shift may relate to the use of rifampicin and streptomycin for treatment of 
the M. ulcerans infection, but this needs to be further investigated. In any case, only 13% of all the 
30 included patients carried rifampicin resistant S. aureus isolates in the present study, indicating 
that the BU treatment might not have a strong effect on the genetic population structure of S. 
aureus in the wounds.
A total of 99%, 77% and 65% of the collected S. aureus isolates were resistant to penicillin, 
tetracycline and chloramphenicol, respectively. This is not surprising as these antibiotics are 
frequently prescribed in healthcare institutions or readily accessible in pharmacies in Ghana. 
Similarly, a high resistance to penicillin (73.7-100%) [39,40] and tetracycline (21.8-92%) [41,42] 
has been reported for MSSA isolates in other African countries, including Algeria, Nigeria, and 
Sao Tome and Principe. Notably, S. aureus isolates that belonged to the same MLVF cluster 
from individual BU patients  included in our present study often presented the same antibiotic 
resistance pattern. Furthermore,  13% of the 91 selected S. aureus isolates were MRSA, one of 
which was a borderline oxacillin resistant S. aureus. These MRSA isolates were obtained from 5 
of the 30 included BU patients (17%). This implies that the MRSA carriage rate in the sampled 
BU patient cohort was lower than the 33% [11] and 38% [10] observed in other cohorts of BU 
patients. From a clinical point of view, it is relevant to mention that three patients carried MRSA 
and MSSA at the same time, indicating that MRSA can be missed if only single isolates are tested 
for resistance. This could then result in an inappropriate antibiotic therapy.
Some BU patients were colonized with S. aureus that belonged to the same MLVF  cluster but had 
different agr types. The presence of different agr types of the same S. aureus genotype may play 
different roles by cross-group interference, which may confer  a selective survival advantage for 
these genotypes over time [43]. agr-negative S. aureus have been shown to have high colonization 
potential through the formation of biofilms thereby contributing to persistent infection [44,45]. 
MLVF cluster M, comprised isolates that are all agr-negative. These isolates were obtained from 
the anterior nares of two patients suggesting that these individuals may be persistent nasal S. 
aureus carriers. Wound colonization of BU patients with PVL-positive S. aureus was observed for 
79% patients, which appears in line with previous studies that have associated PVL with skin and 
soft tissue infections [46,47]. It is tempting to speculate that this could easily be confused with the 
commonly observed paradoxical response in BU patients [6], where  the size of lesions increases 
upon effective antibiotic therapy against M. ulcerans.
In summary, the present study showed that 26% of the investigated BU patients were colonized 
with the same S. aureus types in the anterior nares and wounds during the time period of 
investigations. Furthermore, patients were colonized with S. aureus types that grouped up to two 
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MLVF clusters at the same time point. Over time, changes in the S. aureus wound population 
were observed. Notably, our data suggest that patient transmission events have occurred since 
some S. aureus MLVF clusters were shared by different patients at overlapping time points. This 
emphasizes the need for appropriate wound care and hospital hygiene. Since S. aureus is in 
general capable of interfering with wound healing and since several of the identified isolates are 
resistant to clinically relevant antibiotics, it will be important to further investigate the role of S. 
aureus in wound healing in BU patients and to uncover the reservoirs from which this pathogen 
is transmitted to this patient group.
Supporting Information Legends
S1 Table. S. aureus isolates from BU patients listed in the order of the MLVF dendrogram. 
https://doi.org/10.1371/journal.pntd.0003421.s001
S1 Figure. Frequency of S. aureus isolation from different BU patients.
The different colors represent the types of samples from which S. aureus isolates were obtained: yellow 
– nasal swab, orange – wound swab, red – wound dressing. A white field indicates that the patient 
did not report to the healthcare centre, and a grey field that S. aureus was not detected. The successive 
time points at which samples were collected at the health centre are marked t1 to t13. https://doi.
org/10.1371/journal.pntd.0003421.s002
S1 Checklist. STROBE checklist of items that should be included in reports of observational studies. 
https://doi.org/10.1371/journal.pntd.0003421.s003
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Buruli ulcer (BU) is a skin infection caused by Mycobacterium ulcerans. The wounds of most patients 
are colonized with different microorganisms, including Staphylococcus aureus.
Methodology
This study investigated possible patient-to-patient transmission events of S. aureus during wound 
care in a health care center. S. aureus isolates from different patients with overlapping visits to 
the clinic were whole genome sequenced and analyzed by a gene-by-gene approach (MLST+). 
In addition, sequence data were screened for the presence of antibiotic resistance genes that 
conferred antibiotic resistance.
Principal Findings
MLST+ confirmed transmission of methicillin resistant S. aureus and methicillin susceptible S. aureus 
among patients that took place during wound care. Interestingly, our sequence data show that 
the investigated MRSA isolates carry a novel allele of the fexB gene conferring chloramphenicol 
resistance, which had thus far not  been observed in S. aureus.
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Introduction
Buruli ulcer (BU) is a neglected necrotizing skin disease caused by Mycobacterium ulcerans, with 
the highest burden of the disease in West Africa, particularly in Benin, Cote d’Ivoire and Ghana 
[1]. The disease usually starts as a nodule, plaque, oedema or papule and progresses to form large 
ulcers with undermined edges if left untreated. It was previously shown that wounds of most BU 
patients are heavily colonized by many microorganisms, including Staphylococcus aureus [2,3].
S. aureus can be part of the human microbiota colonizing the skin and mucosal membranes 
without any clinical manifestations. However, once it crosses the skin barrier, or when the host 
immune system is compromised, this bacterium is able to cause a wide range of diseases, such 
as skin and soft tissue infections, osteomyelitis, pneumonia, meningitis, or bacteremia [4,5]. 
Therefore, S. aureus is considered a dangerous pathogen in both community-acquired and 
nosocomial infections. Colonization of healthy individuals with multi-drug resistant S. aureus is 
regarded as a risk factor for future development of S. aureus infections that are difficult to treat [6]. 
The S. aureus colonization of patients with a serious breach of skin barrier, such as patients with 
BU, burn wounds or the group of hereditary mechanobullous diseases epidermolysis bullosa (EB), 
was previously shown to be very high [2,3,7–9]. Molecular typing of S. aureus isolated from the 
wounds of BU and EB patients has shown that their wounds often harbor multiple genotypes of 
this pathogen [3,10].
Recently, several S. aureus clones have been reported in health care institutions in Ghana with 
the sequence types (ST) 15, 121 and 152 being the most prevalent as determined by multi-
locus  sequence typing (MLST) [11]. Notably,  health  care-associated infections (HAIs) caused 
by S. aureus impose a significant burden on patient care as a result of prolonged hospital 
stays, increased cost of treatments and high morbidity and mortality rates. Current practices 
implemented to reduce HAIs include cleaning of the hospital environment, hand hygiene and 
screening and decolonization of patients and health care workers [12–15]. Epidemiological data 
and molecular typing methods, such as pulsed- field gel electrophoresis (PFGE), MLST, spa-
typing, multiple-locus variable number tandem repeat fingerprinting (MLVF), and whole genome 
sequencing (WGS) of the infecting strains can be used to trace transmission events [16–19]. Each 
of these typing methods has particular advantages [20]. For example, MLVF is fast, cheap and 
highly discriminatory [21], while WGS provides detailed information on the genetic makeup of 
investigated isolates.
BU patients may be at risk of hospital-associated colonization with S. aureus due to their frequent 
visits to particular health care centers for wound care. This represents an additional health risk for 
these patients, even if they are already colonized with community-acquired S. aureus. Therefore, 
the present study was aimed at uncovering possible S. aureus transmission events among BU 
patients using MLVF and WGS. Furthermore, WGS was applied to identify antimicrobial resistance 
(AMR) genes and to screen for mutations in genes that confer certain resistance phenotypes. 
The results obtained underpin the potential of the combined use of MLVF and WGS for the 
surveillance of S. aureus outbreaks in hospital settings.
Molecular characterization of Staphylococcus aureus isolates transmitted between patients with Buruli ulcer
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Materials and methods 
Ethical Statement
The ethical committee of the Noguchi Memorial Institute for Medical Research (NMIMR)  (FEDERAL 
WIDE ASSURANCE FWA 00001824) approved the use of clinical samples for this investigation. 
Samples were collected upon written informed consent from adult subjects and a parent or 
guardian of any child participant on their behalf.
Bacterial isolates and genomic DNA extraction
A subset of the S. aureus isolates from BU patients that were previously collected and grouped by 
MLVF into thirteen clusters (A-M) [3] were selected for WGS (Fig. 1). For the present study, isolates 
were selected from each of the thirteen MLVF clusters, and from two clusters suspected of patient-
to-patient transmission events during wound care (clusters H and F). Screening of BU patients for 
the presence of S. aureus had been repeated every two weeks for a period of seven months, 
which defined the sampling time points t1 to t13 in this study (Table 1). Patients involved in this 
screening were at different stages of the disease and treatment for BU. All presently investigated 
S. aureus isolates were obtained from positive anterior nares and wound cultures of eleven BU 
patients who attended the Pakro Health Center in the Eastern region of Ghana for antimicrobial 
therapy (Table 1).
Genomic DNA was extracted from S. aureus isolates grown overnight on blood agar by using 
the Ultraclean microbial DNA isolation kit (mo bio laboratories, Inc, Carlsbad, California, USA) 
according to the manufacturers’ instruction.
Table 1. Frequency of S. aureus with different spa-types isolated during patient visits for wound care
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‘p’ indicates that a patient visited the health center, but no S. aureus was detected. ‘x’ indicates that a patient did not 
visit the health center at the respective time point of sampling. Cells with a red background indicate involvement of 
the respective S. aureus isolates in transmission events. spa-types marked with yellow highlight isolates that were 
sequenced. ‘t1’ to ‘t13’ refers to the time points at which samples were collected.
Whole genome sequencing, sequence assembly and data analyses
DNA libraries were prepared using the Nextera XT v2 kit (Illumina, San Diego, CA, USA) according 
to the manufacturer’s instructions and then run on a Miseq (Illumina) for generating paired-end 
250-bp reads. De novo sequence assembly was performed using CLC Genomics Workbench v7.0.4 
(CLC bio A/S, Aarhus, Denmark) after quality trimming (Qs > 28) with optimal word sizes based on 
the maximum N50 value. The assembled files were imported as Fasta files into SeqSphere+ (MLST+) 
software version 1.1 (Ridom GmbH). The sequence data of the 21 isolates were characterized 
by using the core genome multilocus sequence typing, S. aureus accessory genes and S. aureus 
MLST+ target definer function with the default parameters of the software as previously described 
[22]. The complete sequence of each isolate was analyzed based on gene by gene comparison 
with the reference S. aureus strain COL (GenBank accession no. NC_002951). Each allele was 
assigned a number and an allelic typing profile based on the combination of all alleles for each 
isolate by the software. A dendrogram of the sequenced isolates and two additional reference 
genomes that represent different sequence types (ST5 [N315 GenBank accession no. BA000018.3] 
and ST8 [COL]) was generated using an unweighted-pair group method using average linkages 
(UPGMA).  The concordance between the two typing methods was calculated with the Ridom 
EpiCompare software version 1.0 as described previously [19].
Transmission events
In this study a transmission event is defined to have occurred if the wound of a patient, previously 
not  containing a particular S. aureus genotype, becomes colonized over time by an S. aureus with 
a genotype that is identical with the genotype of an S. aureus isolate collected from the wound 
of another patient. In our previous study, S. aureus isolates from BU out-patients, who visited the 
health center for wound care, were suspected to be involved in patient-to-patient transmission 
events [3]. These isolates were initially grouped by MLVF into clusters H and F (Fig. 1). Here we 
investigated whether transmission events had indeed occurred during wound care of patients 
treated in the Pakro Health Center, using WGS as the reference test.
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Figure 1. MLVF dendrogram of 21 S. aureus isolates from BU patients.
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Screening for antimicrobial resistance
De novo assembled genome sequences of S. aureus isolates were queried against specific 
previously identified sequence features, or compared to complete S. aureus reference genomes 
with associated annotated genes using the WebACT comparison tool (http://www.webact.org/
WebACT/prebuilt#). Further detailed analyses were performed with the Artemis Comparison 
Tool (ACT) software [23]. Specifically sequence data were queried for the presence of SCCmec 
elements and AMR genes. Similarity matches were filtered based on their length and percentage 
similarity scores, and only the filtered hits were then displayed by ACT. The AMR genes that 
were screened confer resistance to chloramphenicol, clindamycin, erythromycin, fusudic acid, 
kanamycin, lincosamide, methicillin, mupirocin, penicillin, streptogramin A and B, tetracycline, 
trimethoprim, tobramycin, and/or vancomycin.
Results
Phylogeny of sequenced S. aureus isolates found in BU patients in Ghana based on a gene-
by-gene comparison
From a total of 13 BU patients who visited the Pakro Healthcare Center for wound care 21 S. 
aureus isolates from the anterior nares (n = 4) and wounds (n = 17) were sequenced (Fig. 1). These 
included six MRSA and 15 methicillin susceptible S. aureus (MSSA) isolates. These isolates have 
been previously characterized by MLVF and spa-typing as shown in Table 2 [3].
Data generated by WGS was analyzed with the MLST+ scheme that uses 1861 core genome genes, 
706 accessory genes and seven MLST genes. A dendrogram was generated after MLST+ analysis 
of the 21 sequenced isolates, which revealed 14 cluster types (CTs) (Fig. 2) denoted as 545 (n = 
4), 714 (n = 1), 556 (n = 1), 546 (n = 1), 552 (n = 1), 554 (n = 1), 715 (n = 1), 549 (n = 2), 550 (n = 1), 
553 (n = 1), 555 (n = 1), 547 (n = 4), 551 (n = 1) and 548 (n = 1). This clustering by MLST+ seemed 
to match well with the previous clustering of isolates by MLVF. To calculate the concordance 
between the MLST+ and MLVF data, the Ridom epicompare software 1.0 (Ridom GmbH) was used 
with the Rands Adjusted co-efficient. This revealed a concordance of 0.924.
The 21 sequenced isolates were assigned to eight MLST types, namely ST1, ST5, ST15, ST88, ST121, 
ST152, ST508, and the new ST3019. The ST3019 is a single-locus variant of ST45 at the yqiL locus 
(S1 Table).
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MLVF CT ST spa-
typing 
SCCmec CXT OXA CIP TET CHL TRI STM RIF 
2 BU_G0201_t8 1-12-
2012 
Not yet 8 H 545 88 t786 Iva + mecA  tetM, 
tetL 





5 H 545 88 t786 Iva + mecA  tetM, 
tetL 
fexB    
2 BU_G0202_t2 1-12-
2012 
Not yet 2 H 545 88 t786 Iva + mecA  tetM, 
tetL 
fexB    
19 BU_G1905_t3 5-1-2013 22-7-
2013 
3 H 545 88 t786 Iva + mecA  tetM, 
tetL 





1 J 714 88 t186 IVa + mecA  tetM, 
tetL 
fexB    
22 BU_W22_t4 12-12-
2012 





11 K 546 5 t002 none + + gyrA*      
17 BU_N17Y_t2 28-12-
2012 
N/A 2 B 552 15 t346       drfG   
3 BU_N3_t2 6-12-
2012 















8 L 549 121 t314     tetK catA drfG   
26 BU_G2601A_t9 6-3-2013 21-6-
2013 
9 L 549 121 t314     tetK  drfG  rpoB* 
22 BU_N22_t6 12-12-
2012 





13 C 555 508 t12836          
3 BU_G0301_t8 6-12-
2012 















8 F 547 152 t355     tetK catA  str  
17 BU_N17W_t2 28-12-
2012 





8 D 548 152 t1096     tetK     
Table 2. Genotypic and phenotypic characteristics of 21 S. aureus isolates from BU patients
CXT - cefoxitin, OXA - oxacillin, CIP - ciprofloxacillin, TET - tetracycline, CHL – chloramphenicol, TRI – trimethoprim 
and STM - streptomycin. Phenotypic antibiotic resistance is indicated by a black background. Genes involved in 
specific resistance phenotypes are indicated in white. The ‘*’ symbol indicates a mutation in a core genome gene 
that is involved in antibiotic resistance.
Evidence of patient transmission events
A first transmission event was identified for four MRSA isolates belonging to ST88, which were 
previously grouped in the MLVF cluster H (Fig. 1) [3]. These isolates were classified by MLST+ as 
cluster type (CT) 545 (allelic profiles within this cluster were identical). Of note, the four isolates 
were obtained from three different patients visiting the healthcare center over a period of seven 
months. The medical care for these patients involved antibiotic treatment and wound dressing 
changes (Tables 1 and 2). This particular MRSA was first identified in the wound of patient 2, who 
tested negative at the first sampling time point (t1). Patient 2 was the first to start treatment in 
this study and was found to carry this particular S. aureus genotype at several sampling time 
points during treatment (i.e. at t2, t3, t8 and t9). Patients 7 and 19 started treatment 25 and 35 
days later, respectively. They both visited the health care center for wound care at time point t2. 
The wounds of patients 7 and 19 tested positive for S. aureus with the MLST+ genotype of CT 
545 at the sampling time points t5 (patient 7) and t3 (patient 19; Table 1), which is indicative of 
transmission events.
A second suspected transmission event was initially identified by MLVF typing (cluster F) and 
involved eight BU patients [3]. To investigate this possible transmission event in more detail four 
of the 25 isolates obtained from three patients were randomly selected and sequenced. These 
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four MSSA ST152 isolates were assigned to the MLST+ CT 547 (Table 2). Patients 10 and 11 tested 
positive for S. aureus with this particular genotype at the same sampling time point (t2). Patient 10 
remained positive for S. aureus with the CT 547 until sampling time point t8, and patient 11 until 
time point t5 (Table 1). A third patient (patient 3) was found to be positive for S. aureus with the 
CT 547 at sampling time point t8 (Table 1). Patients 5, 6, 7, 18 and 24 became positive for S. aureus 
with this genotype at later time points than patients 10 and 11. The patients 5, 6, 7, 18 and 24 paid 
at least one visit at the health center for wound care that overlapped with visits by three other 
patients, which were found to be positive for the S. aureus genotype with the CT 547 (Table 1).
It is noteworthy to mention that in each of the transmission events, the gene allele variation 
between isolates was not higher than one. This implies that the isolates were nearly identical with 
respect to their core genome.
Figure 2. MLST+ dendrogram of 21 sequenced S. aureus isolates from BU patients. 
The dendrogram was generated using the UPGMA algorithm. The reference strains COL (GenBank accession no. 
NC_002951) and N315 (GenBank accession no. BA000018.3) were included in the dendrogram.
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Antibiotic resistance genes
The assembled genomes of the 21 S. aureus isolates were used in blast comparisons to detect the 
presence of AMR genes, and the results are shown in Table 2. Among the investigated isolates 
none was found to carry genes involved in resistance to erythromycin, fusidic acid, kanamycin, 
mupirocin, rifampicin, or vancomycin. Antibiotic resistance of the sequenced isolates was 
previously most often found against penicillin, chloramphenicol, tetracycline and trimethoprim 
[3]. Consistent with their penicillin resistance, all sequenced isolates carried various types of blaZ 
operons, which were located on chromosomally integrated transposons or plasmids. Specifically, 
the blaZ gene was found in 16 isolates that belonged to ST1, ST5, ST15, ST88, ST152 and ST3019, 
while the blaZ-B variant was found in five isolates representing ST5, ST508 and ST121. Fourteen 
sequenced S. aureus isolates were chloramphenicol resistant of which six (ST121, ST3019 and 
ST152) carried various plasmids with a catA gene. Six other isolates (ST88 and ST1) carried 
a novel allele of fexB that was not previously reported in S. aureus. In case of one isolate, the 
phenotypic resistance for chloramphenicol could not be confirmed at the genomic level, which 
was potentially due to the loss of the resistance gene. Resistance to tetracycline was identified in 
16 isolates and confirmed by the identification of resistance genes, such as tetK, tetL and tetM. The 
tetK gene was located on plasmid pT181, which was found in 10 isolates representing different 
STs. Five isolates of ST88 contained the tetL and tetM genes located on identical mobile genetic 
elements integrated into their genomes, while one isolate of ST15 contained a transposon 
with tetM. The presence of a plasmid or transposon carrying the drfG gene responsible for 
trimethoprim resistance was detected in five isolates that belonged to ST5, ST15 and ST121. 
Resistance to streptomycin was limited to three isolates of ST152 where the str gene was present. 
Of the six methicillin resistant isolates, five belonging to ST88 contained the mecA gene, whereas 
one ST5 isolate contained neither mecA nor mecC. The latter isolate was termed borderline 
oxacillin resistant S. aureus (BORSA). Intriguingly, the BORSA isolate contained no mutations in the 
genes for the penicillin- binding proteins PBP1, PBP2, and PBP3 or the YjbH protein, which were 
previously proposed to be involved in BORSA phenotypes [24]. However, sequence comparisons 
revealed that the PBP2 protein of the BORSA isolate contains a Tyr residue at position 197, while 
the PBP2 protein of S. aureus N315 contains a Cys residue at this position. Furthermore, the BORSA 
isolate showed resistance to fluoroquinolones, which may be due to a specific mutation in the 
gyrase A gene (Ser84Leu).
Lastly, all investigated isolates contained the chromosomally-located czrB gene involved in zinc 
resistance, while 17 isolates contained the cadD gene for cadmium resistance located on various 
plasmids. Fifteen isolates were found to contain the arsenic resistance gene arsB, and seven 
isolates contained also the arsC gene (data not shown).
Discussion
In the present study, we have investigated S. aureus transmission events in BU patients during 
wound care by implementing a WGS-based gene-by-gene typing approach (MLST+). The MLST+ 
scheme grouped the 21 sequenced S. aureus isolates into eight different STs. Sequenced S. aureus 
that belonged to ST88 isolates shared identical characteristics (spa-types t186/t786, SCCmec 
type IVa, PVL-negative) with isolates collected from outpatients in Egypt and Angola, indicating a 
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larger geographic distribution on the African continent [25,26]. The new ST3019 (spa-type t939) 
identified in this study belongs to the same clonal complex (CC45) as ST45 and ST508. Compared 
to ST45 a single locus variation was observed at the yqiL locus for ST3019 and in the aroE locus 
for ST508 (S1 Table).
Using MLST+, we identified two major clusters of S. aureus isolates from different BU patients, which 
may reflect transmission events that occurred during overlapping visits to the Pakro Healthcare 
Center where these patients received wound care. None of these patients carried S. aureus with 
the MLST+ CTs 545 or 547 on their first visit to the Pakro Healthcare Center, strongly suggesting 
that they acquired the respective S. aureus types upon wound care. Interestingly, the majority of S. 
aureus isolates from BU patients belong to lineages characterized by spa-types t786 and t355 that 
have been already reported in health care settings in Ghana [11]. This suggests the nosocomial 
acquisition of these S. aureus types by patient-to-patient transmission between BU patients and 
healthcare workers that may have occurred due to inadequate hygiene. Indeed, it has been 
reported in a recent study that 8 of 11 MRSA transmission events among patients in intensive 
care settings were potentially due to poor hand hygiene [16]. This could probably be avoided 
by wearing gloves and protective gowns, and strict implementation of hand hygiene [27–29]. 
Basic preventive measures, such as adherence to aseptic techniques may further reduce the risk 
of infection thereby improving wound care of patients, provided that gloves, gowns, adequate 
dressing materials, running water and hand rub alcohol are made available. With a steady supply 
and stock of equipment and disposables, routine screening of patients and healthcare workers 
for S. aureus may be less critical.
Genotypic data of the isolates sequenced confirmed the results of the antimicrobial resistance 
profiles described previously [3]. Interestingly, the chloramphenicol resistance of some isolates 
was conveyed by the fexB gene, which was thus far not encountered in S. aureus. On the other 
hand, fexB was previously reported in Enterococcus faecium EFM-1 and Enterococcus hirae EH-1 
isolates from pigs [30]. As Enterococci were previously identified in the wounds of BU patients, it is 
conceivable that the MRSA isolates  acquired the fexB gene by horizontal gene transfer from such 
Enterococci [3]. Furthermore, a BORSA phenotype was identified in an isolate belonging to ST5. 
Such a BORSA phenotype was previously reported for S. aureus isolates with ST1, ST8 and ST15 that 
were implicated in wound infections in Scotland [24]. The presence of specific mutations in the 
genes coding for four proteins, namely PBP1, PBP2, PBP3 and YjbH, was proposed to be involved 
in the BORSA phenotype. However, in the genome sequence of the presently investigated BORSA 
isolate from a BU patient, none of these mutations were found. After genomic comparison of 
the BORSA isolate with the N315 reference genome, the only difference was observed for PBP2, 
where at position 197 a cysteine residue was replaced by a tyrosine residue. However, this PBP2 
amino acid substitution is encoded by the majority of S. aureus genomes available in the NCBI 
database and, therefore, it may not explain the BORSA phenotype observed. Further comparative 
genome analyses revealed about 300 additional non-synonymous SNPs, which could contribute 
to the observed BORSA phenotype.
In summary, WGS of S. aureus isolates from BU patients and the subsequent analysis of sequencing 
data using the MLST+ scheme revealed likely patient-to-patient transmission events in a 
healthcare setting in Ghana. This indicates a need for the implementation of improved hygiene 
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protocols in healthcare settings where BU patients receive wound care. Apart from the detection 
of transmission events, WGS has the advantage that it also provides information on antimicrobial 
resistance. Related to the antimicrobial resistance pheno- and genotypes identified in S. aureus 
isolates from BU patients, it is important to bear in mind that antimicrobial pressure has the 
potential to aggravate resistance, with an inherent risk for transmission of resistant organisms. 
Therefore, even in low-resource settings, antimicrobial stewardship programs are likely to have 
added value, with more restrictive antimicrobial use than currently practiced [2].
Supporting information legend
S1 Table. Information on reference genomes from which the antibiotic resistance genes were 
queried. https://doi.org/10.1371/journal.pntd.0004049.s001
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Abstract
Buruli ulcer (BU) is a necrotizing infection of the skin and subcutaneous tissue caused by 
Mycobacterium ulcerans. BU wounds may also be colonized with other microorganisms including 
Staphylococcus aureus. This study aimed to characterize the virulence factors of S. aureus  isolated 
from BU patients. Previously sequenced genomes of 21 S. aureus  isolates from BU patients were 
screened for the presence of virulence genes. The results show that all S. aureus isolates harbored 
on their core genomes genes for known  virulence factors like α-hemolysin, and the α- and 
β-phenol soluble modulins. Besides the core genome virulence genes, mobile genetic elements 
(MGEs), i.e. prophages, genomic islands, pathogenicity islands and a Staphylococcal cassette 
chromosome (SCC) were found to carry different combinations of virulence factors, among 
them genes that are known to encode factors that promote immune evasion, superantigens and 
Panton- Valentine Leucocidin. The present observations imply that the S. aureus isolates from BU 
patients harbor a diverse repertoire of virulence genes that may enhance bacterial survival and 
persistence in the wound environment and potentially contribute to delayed wound healing.
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Introduction
Staphylococcus aureus is one of the most common bacteria residing in chronic wounds, including 
the Buruli ulcers (BU) caused by Mycobacterium ulcerans (Amissah et al., 2015b; Barogui et al., 
2013). The presence of S. aureus is a potential risk for wound infections, especially if they produce 
virulence factors that outweigh the hosts’ ability to resist them. In fact, S. aureus  is notorious 
for producing a range of virulence factors that are involved in the persistence of colonization, 
infection, tissue damage and delayed wound healing (Bessa et al., 2015).
The major known virulence factors of S. aureus include cytolytic toxins such as the hemolysins, 
α-toxin, various leucocidins (e.g. Panton-Valentine Leucocidin [PVL] and exofoliative toxins [ETA 
and ETB]), and phenol-soluble modulins [PSMs]), as well as superantigens such as the toxic 
shock syndrome toxin-1 (TSST-1) (Prévost et al., 2001; Wang et al., 2007). Production of particular 
virulence factors by S. aureus can sometimes be related to specific diseases. This is exemplified 
by the toxic shock syndrome caused  by TSST-1-positive isolates, or the staphylococcal scalded 
skin syndrome caused by ETA- or ETB-positive isolates (Todd et al., 1978). However, in general 
the severity of S. aureus infection seems to be related to the range and amounts of different 
toxins that are simultaneously produced (Otto, 2012). In addition, other virulence factors 
enhance the capacity of S. aureus to survive in the human host. These include immune  evasion 
factors, such as staphylokinase (Sak), the staphylococcal inhibitor of complement  (SCIN), and 
the chemotaxis inhibitory protein (CHIPS). Most often these virulence factors are encoded on 
mobile genetic elements (MGEs), such as prophages, plasmids, genomic islands, staphylococcal 
cassette chromosome (SCC) elements, and S. aureus pathogenicity islands (SaPIs) (Novick, 2003). 
Additionally, the genome of S. aureus contains specific genes with a function in pathogenesis and 
host adaptation. Many of  these are controlled by the accessory gene regulator (agr) system that 
has a major impact on the virulence of S. aureus (Novick et al., 1993).
PVL is one of the prophage-encoded virulence factors implicated in S. aureus necrotic skin 
lesions (Novick, 2003; Novick et al., 1993). The PVL genes have been detected in 53-62% of S. 
aureus isolates from skin and soft tissue infections (Kilic et al., 2015; Nurjadi et al., 2015; Pardos 
de la Gandara et al., 2015). In a recent  study, we observed that 79% of the S. aureus isolates from 
wounds of BU patients treated with streptomycin and rifampicin were PVL-positive (Amissah et 
al., 2015b). Since M. ulcerans is effectively killed upon this antibiotic therapy, we hypothesized that 
the wound-resident S. aureus may still affect the soft tissue, thereby causing a delay in wound 
healing. As PVL is one of many known S. aureus virulence factors, the present study aimed to 
reveal all virulence genes present in S. aureus isolates from BU patients. To this end, the genomes 
of 21 S. aureus isolates from the anterior nares and wounds of BU patients were sequenced and 
analyzed for the presence of known virulence genes.
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Table 1. Detection of genes for hemolysins and phenol soluble modulins. 
 
Patient no. ST Strain1 Source of sample agr type hla2,3 hlb2,4 hld2 Psm-α2 Psm-β2 
2 88 BU_G0201_t8* Wound III + a + + + 
7 88 BU_G0701_t5* Wound III + a + + + 
2 88 BU_G0202_t2* Wound III + a + + + 
19 88 BU_G1905_t3* Wound III + a + + + 
13 88 BU_W13_t1* Wound III + a + + + 
22 5 BU_W22_t4 Wound II + a + + + 
7 5 BU_W7A_t11* Wound II + a + + + 
17 15 BU_N17Y_t2 Nose II + b + + + 
3 15 BU_N3_t2 Nose II + b + + + 
6 1 BU_W6_t1 Wound III m a + + + 
12 121 BU_G1201_t13 Wound IV + a + + + 
12 121 BU_G1201_t8 Wound IV + a + + + 
26 121 BU_G2601A_t9 Wound IV + a + + + 
22 3019 BU_N22_t6 Nose IV + a + + + 
12 508 BU_W12_t13 Wound IV + a + + + 
3 152 BU_G0301_t8 Wound IV + + + + + 
10 152 BU_G1074_t4 Wound IV + + + + + 
11 152 BU_G1101_t2 Wound IV + + + + + 
10 152 BU_G1001_t8 Wound IV + + + + + 
17 152 BU_N17W_t2 Nose IV + + + + + 
7 152 BU_G0706B_t8 Wound IV + + + + + 
Materials and methods 
Ethical Statement
The study was approved by the ethics committee of the Noguchi Memorial Institute for Medical 
Research (FEDERAL WIDE ASSURANCE FWA 00001824), and was carried out in accordance with 
the approval guidelines. All samples were collected upon written informed consent from adult 
subjects, or a parent or guardian of any child participant on behalf of the respective child below 
18 years. Specifically, samples were collected from the anterior nares and wounds of eleven BU 
patients who received treatment at the Pakro Health Center in the Eastern region of Ghana.
Table 1. Detection of genes for hemolysins and phenol soluble modulins
1 MRSA isolates are indicated by an asterisk; 2 Detection of hemolysins and phenol soluble modulin genes is 
indicated by +; 3 a frame shift mutation in the hla gene is marked by m. 4 Insertion of a prophage and IEC genes in 
the hlb gene are marked a and b.
Bacterial isolates
The 21 S. aureus isolates used in this study are listed in Table 1. Their isolation and  initial 
characterization was described (Amissah et al., 2015a). Specifically, four isolates were obtained 
from the anterior nares and 17 from the wounds of eleven BU patients. These included six 
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Hemolytic activity of S. aureus isolates from BU patients
S. aureus isolates were grown overnight in 3 ml of Tryptic Soy Broth (TSB) at 37˚C. A 10 µl loopful 
of the S. aureus RN4220 control strain was streaked vertically at the center of freshly prepared 5% 
sheep blood agar (BA) plates. Next, the 21 investigated S. aureus isolates from BU patients were 
streaked perpendicularly on both sides of the RN4220 streak. Plates were incubated overnight at 
37˚C after which the possible synergistic hemolytic activity was assessed by visual inspection of 
clearance zones due to the lysis of red blood cells.
Whole genome sequencing, sequence assembly and data analyses
Genomic DNA for whole genome sequencing (WGS) was obtained from S. aureus isolates as 
previously described (Amissah et al., 2015a). DNA libraries were prepared using the Nextera XT v2 
kit (Illumina, San Diego, CA, USA) according to the manufacturers’ instructions and then run on a 
Miseq (Illumina), which resulted in paired- end reads of ~250-bp. De novo sequence assembly  was 
performed using the CLC Genomics Workbench v7.0.4 package (CLC bio A/S, Aarhus, Denmark) 
after quality trimming (Qs > 28) with optimal word sizes based on the maximum N50 value. The 
sequence reads were submitted to the National Center for Biotechnology Information GenBank 
and are available under the BioProject PRJNA283747, SRP (raw reads) study accession: SRP061319 
and accession numbers: LGAE00000000, LFTW00000000, LFTV00000000, LFTU00000000, 
LFTT00000000, LFOH00000000, LFOG00000000, LFNS00000000, LFNR00000000, LFNQ00000000, 
LFNP00000000, LFNO00000000, LFNN00000000, LFNM00000000, LFNL00000000, LFNK00000000, 
LFNJ00000000, LFNI00000000, LFNH00000000, LFMH00000000, LFMG00000000.
Screening for virulence genes and mobile genetic elements
De novo assembled genomes of sequenced S. aureus isolates were queried against specific 
features of previously sequenced isolates, or compared to the complete S. aureus reference 
genome of MRSA252 with associated annotated genes (NCBI number: BX571856.1) using blastN 
in the WebACT comparison tool (http://www.webact.org/WebACT/prebuilt#). Subsequent 
detailed analyses were performed with the Artemis Comparison Tool (ACT) software (Carver et al., 
2005). Similarity matches were filtered based on their length (100 kb segments) and percentage 
similarity scores, and only the filtered hits with at least 80% sequence similarity were then 
displayed by ACT (e-value of 10.00000) and analyzed in detail. Sequence data were queried for 
the presence of staphylococcal enterotoxin genes (sea, seb, sec1, sec3, sec4, sed, see, seg, seh, sei, 
sej, sek, sel, sem, sen, seo, sep and seq), the toxic shock syndrome toxin-1 gene (tsst-1), exfoliative 
toxin genes (eta and etb), cytolytic toxin genes, phenol-soluble modulin genes (psm-α, psm-β and 
psm-γ) and PVL genes (lukF-PV and lukS-PV). In addition, the presence of genes encoding proteins 
that have impact on the innate and adaptive immune system was assessed, including genes for 
the chemotaxis inhibitory protein (chp), staphylokinase (sak) and staphylococcal complement 
inhibitor (scn). Lastly, the presence of known and potential prophages, genomic islands, SaPIs and 
SCCmec elements was investigated by similarity searches.
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Results
Dynamics of S. aureus in wounds of BU patients and wound healing time
As reported previously we determined S. aureus diversity over time in the wounds of 19 BU 
patients (Amissah et al., 2015b). Most of the patients were diagnosed with category II wounds 
(i.e. lesions between 5 and 15 cm) and time to healing ranged from 2.75 to more than 6 months 
(Table 2). In most cases, the patients’ wounds were colonized by MSSA, but MRSA was detected in 
the wounds of five patients. The investigated wounds were colonized by S. aureus before, during, 
and after antibiotic treatment (Amissah et al., 2015b). We observed that three patients (patients 
2, 10 and 11) were colonized with a single S. aureus genotype over time, while two other patients 
(patients 13 and 19) were found to be positive with S. aureus only once during the study period 
(Amissah et al., 2015b). Two different S. aureus genotypes were identified simultaneously at the 
same time point in the wounds of three patients (patients 6, 12 and 26). Remarkably, the wounds 
of three patients (patients 3, 22 and 7) were colonized over time with three, four or even six 
different S. aureus genotypes, respectively.
Detection of hemolysin and phenol soluble modulin genes
To assess the virulence genes of S. aureus isolates from the wounds of BU patients, we first queried 
the core genome for generally well-conserved virulence genes, including those that encode 
α, β, and δ-hemolysins (hla, hlb and hld) and phenol soluble modulins (psm-α and psm-β). All 
investigated isolates harbored the hla gene. However, in one isolate with sequence type 1 (ST1), 
it contained a frame shift mutation caused by a nucleotide deletion (Table 1). The hlb gene was 
found to be intact in all isolates that belonged to ST152, while in most other isolates this gene 
was split into two parts by insertion of a prophage (φSa3). However, in isolates belonging to ST15, 
the hlb gene was split by an immune evasion gene cluster (IEC). The hld and the psm-α and psm-β 
genes were present in all isolates (Table 1).
Despite the presence of hla encoding α-hemolysin in the genomes of almost all sequenced 
isolates, α-hemolysin activity was observed only in isolates that belonged to ST152 (Table 2). This 
may relate to the limited sensitivity of the applied assay for weak α- hemolysin activity. β-hemolysin 
activity was detected in ten isolates of which four belonged to ST88 and six to ST152 (Table 2). 
The detection of a β-hemolysin-like activity in the four ST88 isolates was unexpected as they lack 
an intact hlb gene due to phage integration (Table 1). Lastly, 13 isolates displayed δ-hemolysin 
activity (Table 2). Of note, two isolates belonging to ST121 and ST508, respectively, did not display 
any hemolytic activity, despite the presence of the hla and hld genes (Tables 1 and 2).
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Hla4 Hlb4 Hld4 
2 88 BU_G0201_t8 Wound II 16 > 6*  + + 
7 88 BU_G0701_t5 Wound II 7 6  + + 
2 88 BU_G0202_t2 Wound II 4 > 6*  + + 
19 88 BU_G1905_t3 Wound II 2 > 6  + + 
13 88 BU_W13_t1 Wound II 0 4.5   + 
22 5 BU_W22_t4 Wound III 7 > 6*   + 
7 5 BU_W7A_t11 Wound II 20 6   + 
17 15 BU_N17Y_t2 Nose N/A N/A N/A   + 
3 15 BU_N3_t2 Nose N/A N/A N/A   + 
6 1 BU_W6_t1 Wound III 0 4.5   + 
12 121 BU_G1201_t13 Wound II 26 > 6*   + 
12 121 BU_G1201_t8 Wound II 14 > 6*   + 
26 121 BU_G2601A_t9 Wound II 3 3.5    
22 3019 BU_N22_t6 Nose N/A N/A N/A   + 
12 508 BU_W12_t13 Wound II 26 6    
3 152 BU_G0301_t8 Wound III 15 > 6* + +  
10 152 BU_G1074_t4 Wound III 7 4.5 + +  
11 152 BU_G1101_t2 Wound II 3 2.75 + +  
10 152 BU_G1001_t8 Wound III 15 4.5 + +  
17 152 BU_N17W_t2 Nose N/A N/A N/A + +  
7 152 BU_G0706B_t8 Wound II 13 6 + +  
Table 2. Investigated S. aureus isolates and their hemolytic activity
1 Abbreviations used: ST, sequence type; N/A, not applicable; 2 Numbers indicate the category of lesions: I, lesions ≤ 
5 cm; II, lesions between 5 and 15 cm; III, lesions ≥ 15 cm or lesions at critical sites such as the eye and genitals; 3 An 
* indicates the end of observation; 4 Hemolytic activity is indicated by a +
Virulence genes located on mobile genetic elements
To gain further insight into the genomic diversity of S. aureus isolates from BU patients and the 
features that may influence host colonization and infection, the genomes of the 21 sequenced 
isolates were analyzed for the presence of mobile genetic elements that could potentially encode 
virulence factors (Table 3). Indeed, 20 isolates carried at least one prophage, while in one isolate 
belonging to ST15 no intact prophage was detected. Different combinations of virulence genes 
were encoded by the identified prophages. The most common prophage type (φSa3) was 
identified in 19 S. aureus isolates. The prophage φSa2 was detected in 17 isolates, but isolates 
belonging to ST88 and ST3019 contained prophage φSa2 without the genes encoding PVL. One 
ST15 isolate harbored the φSa6 that encoded the eta gene (Table 3).
Interestingly, analysis of the integration sites of φSa3 showed three genomic positions that may 
be occupied by this phage type (Fig. 1). Most often this phage was found to split the hlb gene into 
two parts as illustrated in Figure 1 for ST88, ST5, ST1, ST121 and ST508 isolates (top to bottom). 
This is similar to the situation encountered for phiNM3 in strain Newman (DQ530361.1; Fig. 1) 
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(Bae et al., 2006). Isolates belonging to ST15 carried the IEC gene cluster (chp and scn) at the hlb 
position, while an intact prophage was missing (not shown). The second locus where the φSa3 
prophage had inserted was into the hsdS gene, which encodes a specificity subunit of the type I 
restriction modification system that is present within the β-genomic island (νSaβ). This location of 
φSa3 was identified in the genomes of five ST152 isolates (Fig. 1 and Table 3). The third genomic 
position occupied by φSa3 was a non-coding region which, in the reference genome MRSA252, 
is located between the open reading frames (ORFs) SAR0654 and SAR0655 (Fig. 2A). This location 
of φSa3 was only found in the genome of one isolate belonging to ST152 (Fig. 1 and Table 3).
Except two ST508 and ST3019 isolates, the genomes of all other isolates carried the lukD and lukE 
genes for a pore-forming toxin in the highly variable νSaβ genome region (Table 3).
Figure 1. Diversity of φSa3 phages and their genomic integration sites in sequenced S. aureus isolates from BU 
patients.
BLASTN-based alignment (nucleotide identity >80% shown) of the sequences of φSa3 bacteriophages identified 
in 21 sequenced Ghanaian S. aureus isolates as displayed by the Artemis comparison tool (ACT). The previously 
published DNA sequence of phage phiNM3 from strain Newman (NCBI number: DQ530361.1) was used as a 
reference to compare with other bacteriophage sequences included in this alignment. Further, representative 
φSa3 bacteriophages from S. aureus isolates of particular sequence types are shown (ST88 - BU_G0701_t5; ST5 
- BU_W7A_t11; ST1 - BU_W6_t1; ST121 – BU_G2601A_t9; ST508 - BU_W12_t13; ST152 - BU_G0301_t8 and BU_
G0706B_t8). Red lines between compared sequences highlight orthologous sequences with the same orientation. 
Identified open reading  frames (ORFs) are colored in light blue, the integrase gene is marked in yellow, immune 
invasion cluster genes  are indicated in pink and assigned with specific numbers (1- sae; 2 - sak; 3 - chp; 4 - scn). 
Phage  integration points are indicated by roman numbers (I - hlb (green); II - hsdS; III - non-coding region).
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Figure 2. Genomic positions of integrated φSa3 phages (A) and SaPIs (B).
The identified φSa3 phages and SaPIs in sequenced S. aureus isolates are projected onto the MRSA252 reference 
genome. The integration sites are indicated with blue squares.
Novel pathogenicity islands
Analysis of the sequence data of the 21 isolates revealed the presence of eight different SaPIs. 
Remarkably, only one had been previously identified whereas the other seven contained novel 
regions. Furthermore, most of the identified SaPIs had mosaic structures containing regions of 
known SaPIs as well as completely novel genes not identified previously. We named these new 
pathogenicity islands SaPIGhana1 to SaPIGhana7 (Table 3). SaPIGhana1 from isolate BU_W22_t4 
(ST5) is composed of regions belonging to SaPI2 and harbors the ear gene that encodes for a 
penicillin-binding protein (Fig. 3). Additionally, it contains two novel genes whose functions are 
yet unknown. SaPIGhana2 from isolate BU_W7A_t11 (ST5) represents a novel SaPI type that is 
similar to the SaPI from S. aureus strain OC3 (ST8) (Accession No. AB983199.1), which was previously 
isolated in Japan. This SaPI carries the fhuD gene, encoding a ferrichrome-binding protein that 
is important for growth under iron-restricted conditions. Isolate BU_N17Y_t2 (ST15) contains 
SaPIGhana3, which is a SaPI1-like element with a novel region with three genes of unknown 
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function downstream of the terminase gene. The isolate BU_W6_t1 (ST1) contains two SaPIs. 
First, we found SaPIGhana4 that shares homologous regions with SaPI1 and contains a novel 
region that includes the tst and ear genes plus a truncated seb gene. The second pathogenicity 
island found in this isolate, SaPIGhana5, shares homologous regions with SaPImw2. However, this 
SaPI contains a novel region downstream of the terminase gene with three novel genes and the 
eta gene. Three of the isolates belonging to ST121 also contained two novel SaPIs. SaPIGhana6 
(Table 3) is composed of regions similar to two different pathogenicity islands namely SaPImw2 
and SaPIj11, and it harbors the two enterotoxin genes sek and seq. The second SaPI, SaPIGhana7, 
harbors both novel regions and contains regions with high similarity to the previously identified 
SaPIIVm10 (SaPI4). Further, SaPIGhana7 carries the seb and ear genes. Lastly, the SaPI identified in 
isolate BU_W12_t13 (ST508) shares overall similarity with the previously identified SaPI68111. This 
SaPI carries the tst, ear, seb and sel genes. Amongst the analyzed isolates, SaPIs were identified at 
four different genomic positions as mapped on the reference genome of the MRSA252 strain (Fig. 
2B). SaPIGhana4 and 7 had integrated upstream the gene coding for the hypothetical protein 
SAR0365. A second SaPI integration point, where SaPIGhana2, 5 and SaPI68111 were identified, was 
located downstream of the smpB gene coding for the putative tmRNA- binding protein SAR0837. 
A third integration point, where SaPIGhana 3 and 6 were found, was located downstream of the 
ORF coding for the methionine ABC transporter SAR0871. The fourth integration site containing 
SaPIGhana1 was located downstream of the groEL gene.
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Figure 3. Diversity of SaPIs and their integration sites in sequenced S. aureus isolates from BU patients.
Open reading frames (ORFs) are indicated by arrows. Homologous regions to known  SaPIs are indicated 
by colored blocks. Hypothetical ORFs are indicated in blue; the SaPI integrase gene (int) is marked in 
green; genes encoding virulence factors are indicated in orange; novel ORFs are indicated by yellow 
arrows. ter represents the SaPI terminase gene.
Genomic regions downstream the SCCmec insertion site in S. aureus isolates from BU patients
The integration site of known SCCmec elements is localized at the rlmH gene (previously 
designated orfX), encoding a methyltransferase. A detailed inspection of the region downstream 
of rlmH in the sequenced MRSA and MSSA isolates showed that it was conserved in isolates of the 
same sequence type. However, it differed substantially with respect to gene content in isolates 
of different sequence types. Novel genomic regions downstream of rlmH integration sites were 
found in sequenced isolates belonging to ST88, ST152 and ST3019. Five of the investigated ST88 
isolates were MRSA that carried SCCmec IVa. Interestingly, all these five isolates contained a novel 
DNA fragment of 7 kb downstream of the SCCmec element that includes eight open reading 
frames of unknown function (Fig. 4). In this fragment, a stretch of 3.6 kb shares 89% sequence 
similarity with a corresponding region of the SCC element present in S. haemolyticus strain SH480 
(GenBank: AB477967.1).
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Of note, a novel region of 5 kb in size was identified downstream of rlmH in ST152 MSSA isolates. 
This region contains six novel genes encoding hypothetical proteins (Fig. 4). The one investigated 
ST3019 MSSA isolate carried an SCC element with a cap operon that encodes for capsular 
polysaccharide in S. aureus. Downstream of this novel SCC, a new genomic region of 10 kb in 
size was identified that contained 9 novel open reading frames not reported before. Further, five 
different but previously characterized genomic regions downstream of rlmH were encountered 
in the remaining MSSA isolates. Specifically, in the ST5 MSSA isolates the analyzed genomic region 
downstream of  rlmH was identical to that of the S. aureus isolates ED98 (GenBank: CP001781.1) 
and 502A (GenBank: CP007454.1). In ST15 isolates the region downstream of rlmH was identical 
to the respective region of the previously reported 15666 SCCmec insertion site (Noto et al., 
2008). The ST1 MSSA isolate had a genomic region downstream of rlmH identical to the region 
described previously as the 15575 SCCmec insertion site genomic sequence, which contains 
the gene for the enterotoxin Seh. The MSSA isolates with ST121 contained genomic regions 
downstream of rlmH that were identical to the respective region described as the 3289 SCCmec 
insertion site genomic sequence, which carries the sec2 enterotoxin gene. The genomic region 
downstream rlmH in the ST508 isolate is identical to the corresponding region of MRSA strain CA-
347 (GenBank: CP006044.1) (Fig. 4). This region was found to encode a restriction-modification 
system (hsdR hsdM) and to include a MGE encoding an ErmB/QacA drug resistance transporter 
of the major facilitator superfamily (MFS).
Lastly, all investigated isolates contained genomic islands νSaα and νSaβ with varying sets of 
genes encoding exotoxins, enterotoxins, lipoproteins and serine proteases that target elements 
of the innate immune response (Table 3). In addition, the ST1 isolate was found to encode a third 
pore-forming leukocyte toxin, encoded by the lukM and lukS genes.
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Figure 4. Structure of genomic regions downstream of SCCmec insertion sites in sequenced S. aureus isolates from 
BU patients.
Open reading frames (ORFs) are marked by arrows and truncated ORFs are indicated by * above the arrow; rlmH 
(orfX) is indicated in yellow; hypothetical ORFs are indicated in blue; genes coding for antibiotic resistance are 
indicated in red; genes encoding virulence factors are indicated in black; and direct repeats are marked by a black 
arrow head. The novel genomic regions present in isolates of ST88, ST152 and ST3019 are indicated with grey 
shading.
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Table 3. Detection of mobile genetic elements and additional virulence genes. 








BU_G0201_t8 88 - - φSa3 (sak, chp, scn) φSa2 - set(11), lpl(3) lukD, lukE,bsaG, 
spl(8) 
BU_G0701_t5 88 - - φSa3 (sak, chp, scn) φSa2 - set(11), lpl(3) lukD, lukE, bsaG, 
spl(8) 
BU_G0202_t2 88 - - φSa3 (sak, chp, scn) φSa2 - set(11), lpl(3) lukD, lukE, bsaG, 
spl(8) 
BU_G1905_t3 88 - - φSa3 (sak, chp, scn) φSa2 - set(11), lpl(3) lukD, lukE, bsaG, 
spl(8) 
BU_W13_t1 88 - - φSa3 (sak, chp, scn) φSa2 - set(11), lpl(3) lukD, lukE, bsaG, 
spl(8) 
BU_W22_t4 5 SaPIGhana1 
(ear) 
- φSa3 (sak, chp, scn) φSa2 (sea, 
lukF, lukS) 
- set(10), lpl(10) lukD, lukE, seo, 
sem, sei, yent1, 
yent2, sen, seg, 
spl(3) 
BU_W7A_t11 5 SaPIGhana2 - φSa3 (sea, sak, chp, 
scn) 
- - set(10), lpl(9) lukD, lukE, seo, 
sem, sei, yent1, 
yent2, sen, seg, 
spl(5) 
BU_N17Y_t2 15 SaPIGhana3 
(ear) 




set(11), lpl(8) lukD, lukE, spl(6) 
BU_N3_t2 15 - - phage remnants (chp, 
scn) 
- - set(11), lpl(9) lukD, lukE, spl(4) 
BU_W6_t1 1 SaPIGhana4 
(seb, sae, tst-1) 
SaPIGhana5 
(eta) 




- set(11), lpl(5) lukD, lukE, 
lukM/lukS, seh, sej, 
	         ser, seh, spl(6) 




φSa3 (sak, scn) φSa2 (lukF, 
lukS) PVL 
- set(11), lpl(3) lukD, lukE, sec2, seo, 
sei, sec3, sen, 
seg, spl(3) 




φSa3 (sak, scn) φSa2 (lukF, 
lukS) PVL 
- set(11), lpl(3) lukD, lukE, sec2, seo, 
sei, sec3, sen, 
seg, spl(3) 




φSa3 (sak, scn) φSa2 (lukF, 
lukS) PVL 
- set(11), lpl(3) lukD, lukE, sec2, 
seo, sei, sec3, sen, seg, 
spl(3) 
BU_N22_t6 3019 - - φSa3 (sak, chp, scn) φSa2 - set(9), lpl(6) seo, sek, sei, sec1, sen, 
seg 
BU_W12_t13 508 SaPI68111 (sel, 
seb, ear, tst-1) 
- φSa3 (sak, chp, scn) - - set(9), lpl(6) seo, sek, sei, seu, 
sen, seg, sea 
BU_G0301_t8 152 - - φSa3 (sak, scn)* φSa2 (lukF, 
lukS) PVL 
- set(8), lpl(6) lukD, lukE, bsa(8) 
BU_G1074_t4 152 - - φSa3 (sak, scn)* φSa2 (lukF, 
lukS) PVL 
- set(8), lpl(6) lukD, lukE, bsa(8) 
BU_G1101_t2 152 - - φSa3 (sak, scn)* φSa2 (lukF, 
lukS) PVL 
- set(8), lpl(6) lukD, lukE, bsa(8) 
BU_G1001_t8 152 - - φSa3 (sak, scn)* φSa2 (lukF, 
lukS) PVL 
- set(8), lpl(6) lukD, lukE, bsa(8) 
BU_N17W_t2 152 - - φSa3 (sak, scn)* φSa2 (lukF, 
lukS) PVL 
- set(8), lpl(4) lukD, lukE, bsa(8) 
BU_G0706B_t8 152 - - φSa3 (sak, scn)# φSa2 (lukF, 
lukS) PVL 
- set(8), lpl(6) lukD, lukE, bsa(8) 
 
Table 3. Detection of mobile genetic elements and additional virulence genes
*, phage φSa3 integrated into hsdS. #, phage φSa3 integrated into non-coding region
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Discussion
The pathogenesis of BU is associated with mycolactone, the main virulence factor of M. ulcerans 
that is responsible for tissue necrosis and suppression of the immune response of BU patients 
(George et al., 2000, 1999). The resulting wounds are subsequently colonized with different 
bacteria, including S. aureus (Amissah et al., 2015b; Barogui et al., 2013). We hypothesize that S. 
aureus is one of the drivers of delayed wound healing, besides other factors such as poor nutrition 
and inadequate wound management. In the ideal situation, wound management in BU should 
include rinsing with saline, and the application of vaseline gauze topped with absorptive dressing 
material and compression, preferably with a short-stretched bandage. Poor wound management 
and transmission events during wound care predispose the wounds of BU patients to colonization 
with microorganisms including S. aureus (Amissah et al., 2015a; Velding et al., 2014). Hence small 
lesions (<10 cm) that are expected to heal within two to four weeks of antibiotic therapy take longer 
time to heal. For example, in one large trial with drug treatment alone, it took patients a median 
18 weeks to heal (Nienhuis et al., 2010). This may at least partially be due to the colonization with 
bacteria including S. aureus. In our present  study, it took 6 months for most category II wounds 
colonized with S. aureus to heal (Table 2) compared to 3-4 months for patients not colonized with 
S. aureus (data not shown). Furthermore, temporal changes in S. aureus genotypes were observed 
in the wounds of some BU patients (Amissah et al., 2015b). Here, we observed different S. aureus 
genotypes containing additional virulence genes over time (patients 7 and 12) (Table 3). Thus BU 
wounds that are not healed after two months  of antibiotic therapy may even be re-colonised 
with new S. aureus genotypes that can be more virulent than the original colonizing S. aureus. 
In  this respect, it is noteworthy that the S. aureus genotypes identified in BU wounds have also 
been detected in the nares, skin and soft tissue infections, and bacteraemia in Ghana and other 
African countries (Conceicao et al., 2015; Egyir et al., 2014; Kraef et al., 2015; Ruimy et al., 2008; 
Shittu et al., 2012). In  fact, in Ghana, S. aureus contributes largely to bacteraemia (10.8 – 13.2%) 
(Anyebuno and Newman, 1995; Nielsen et al., 2012). Further, patients with skin infections such as 
BU are heavily colonized with S. aureus (Amissah et al., 2015b; Barogui et al., 2013). The BU lesions 
are often colonized by S. aureus during disease management, i.e. during and after antimicrobial 
therapy and wound management (Amissah et al., 2015b). In this respect, it should be noted that 
none of the patients in this study were prescribed antibiotics other than the topical antibiotics 
used during wound dressing.
The present study characterized the virulence genes in S. aureus isolated from BU patients. Genes 
for staphylococcal virulence factors are often encoded by MGEs, such as prophages, plasmids, 
genomic islands and SaPIs. Accordingly, the present study  attributed particular attention to MGEs 
and the encoded virulence and resistance  genes.  In many isolates α-, β- and δ-hemolysin genes 
were found, whereas their activity was  only detected in some investigated S. aureus isolates. In 
the case of two agr-positive MSSA isolates (ST121 and ST508; agr type IV; Table 1) no hemolytic 
activity was detectable. For the respective ST508 isolate, this phenotype may be explained by 
multiple mutations in the agrC locus and RNAIII. On the other hand, in the non-hemolytic ST121 
isolate, the only mutation detected in the agr locus concerned the insertion of one adenine in 
the RNAIII region. It is presently not clear whether this explains the non-hemolytic phenotype. 
Alternatively, it is conceivable that the lack of hemolytic activity was due to a suppression of 
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agr function by upstream regulators, such as sigB, as was previously reported for glycopeptide-
intermediate resistant S. aureus (Bischoff et al., 2001; Bischoff and Berger-Bachi, 2001; Renzoni 
et al., 2004; Sakoulas et al., 2006). The latter observation has been associated with the ability of 
MRSA to survive under glycopeptide selective pressure. Further studies are needed to understand 
the mechanism of the loss of hemolytic activity in the MSSA isolates under rifampicin selection 
pressure against which one isolate is resistant. Of note, the method used in the detection of 
hemolytic activity may not be sensitive enough for the detection of weak α-hemolysin activity, 
which is a potential limitation in this study. Conceivably, the pore-forming activity of the detected 
hemolysins may contribute to tissue necrosis in wounds of BU patients after antibiotic therapy 
of the primary infection caused by M. ulcerans. On the other hand, the virulence of some isolates 
in our study may be affected to some extent by the integration of a prophage or the IEC gene 
cluster in the hlb gene. Indeed such genetic changes have been reported to have the potential 
to enhance the pathogenicity of the isolates (Salgado- Pabón et al., 2014). Intriguingly, four 
isolates belonging to ST88 showed high a β-hemolysin-like activity despite the insertion of a 
prophage in hlb. This implies that an as yet unidentified other factor with β-hemolysin-like activity 
is responsible for this phenotype.
MGEs such as (pro)phages represent a driving force in staphylococcal host adaptation  and 
infection (Wagner and Waldor, 2002). Consistent with this view, almost all isolates carried phage-
encoded virulence factors, particularly those involved in phagocyte evasion by inhibiting 
phagocytosis (CHIPS, SCIN, Sak, and Sea) and by directly attacking phagocytes (PVL) (van der 
Vijver et al., 1972). The insertion of the φSa3 prophage, which encodes CHIPS, SCIN, Sak and Sea, 
into the hlb gene has been reported to serve as a regulator of virulence gene expression by 
increasing fitness and virulence in new infection niches (Salgado-Pabón et al., 2014). It seems 
likely that this will also be true for most of the presently investigated isolates.
Seven novel SaPIs were identified in the sequenced S. aureus isolates from BU patients. These 
were shown to carry genes for virulence factors, such as ear, seb, sae, sek, sel, seq, tst-1 and eta, 
suggesting that the respective staphylococci have the ability to cause infections like sepsis, 
toxic shock syndrome and scalded skin syndrome (Fraser et al., 2000; Holtfreter and Bröker, 
2005; Yamasaki et al., 2005). More importantly, certain combinations of staphylococcal toxin 
genes reported to be rare and associated with mortality were found in the investigated isolates 
(Ambrozova et al., 2013). For instance, SaPIGhana4 encoding tst-1, seb, sae, φSa2 encoding lukF 
and lukS, φSa3 encoding sea, sak, chp, scn, sel, sek, and the additional virulence factors lukM/lukS, 
seh, sej, ser, seh were detected in the genomes of S. aureus isolated from wounds. Further, the 
enterotoxin-encoding genes seg, sei, sem, sen, seo located in the enterotoxin gene cluster (egc) 
were often identified in isolates harboring the novel SaPIs. Epidemiological data suggests that 
egc facilitates the colonization of mucosal surfaces, which precedes local and invasive infection 
and is associated with lower disease-invoking potential as compared to S. aureus superantigens 
(Ferry et al., 2005). This may be one reason why serious infections, such as sepsis or toxic shock 
syndrome, did not occur in the BU patients from whom the investigated S. aureus isolates were 
obtained. Indeed, none of the patients were clinically suspected of having a secondary infection 
with or were treated for a suspected S. aureus infection. This suggests that the presence of certain 
virulence genes may counteract the effects of other virulence factors. It also suggests that multiple 
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virulence factors encoded on MGEs may contribute differentially to the survival and persistence 
of S. aureus in the wound. However, the confirmation of this idea awaits experimental verification 
through expression analyses and testing the isolates in appropriate animal infection models.
The known SCCmec integration site located at rlmH (orfX) deserves special attention also in MSSA 
isolates, because this genomic region seems to be attractive for integration of other non-SCCmec 
elements that may encode virulence or fitness-enhancing determinants. This was clearly the 
case in isolates belonging to ST1, ST121 and ST508 that were found to harbor at this locus the 
enterotoxins genes seh or sec2, or the gene encoding an EmrB/QacA drug resistance transporter, 
respectively (Amissah et al.,  2015b). The identification of an SCC element with a cap operon in an 
S. aureus ST3019 isolate suggests that this isolate may have acquired a fitness advantage as well as 
a phagocytosis-resistance phenotype (Luong and Lee, 2002; Pardo et al., 2009; Voyich et al., 2005). 
However this needs to be further investigated.
The virulence genes sea, sei, lukDE, lukF-PV, lukS-PV, hlgv and cap8 have been associated with 
moderate to severe infections in diabetic foot ulcers (grades 2 - 4) (Messad et al., 2013; Sotto et 
al., 2008). For S. aureus isolates that cause invasive infections, the cap5, lukDE and scn genes, as 
well as genes encoding fibronectin-binding protein (fnbB), serine proteases A and B (splA/splB), 
and staphylococcal exotoxin-like proteins (setC or seIX) have been reported to be frequently 
present (Rasmussen et al., 2013). Although some virulence genes are reported to be associated 
with severe  infections in diabetic ulcers and in patients with invasive staphylococcal disease, this 
study lacks the metadata to make such inference. Nonetheless, one observation is noteworthy 
in this respect, namely that the nasal isolates from patients 3 and 22 seem to have fewer SaPIs, 
prophages and virulence genes than the wound isolates from these patients (Table 3). However, 
it should be noted that the respective nasal and wound isolates belonged to different sequence 
types, which makes it difficult to speculate about possible differences in the virulence of these 
isolates.
In conclusion, the sequence data of S. aureus isolates from BU patients uncovered a large but 
variable reservoir of MGEs and virulence genes that may enhance their survival and persistence 
in the human host. In particular, we identified seven novel enterotoxin- encoding SaPIs from 
BU patients. It should however, be noticed that this study provides only a first inventory of the 
virulence potential of the investigated isolates. Accordingly, we cannot yet correlate clinical data 
(e.g. percentage change in wound size over time) with the presence or absence of particular 
virulence genes. In addition, the virulence potential or presence of other bacteria such as 
Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii, Klebsiella pneumonia and 
S. haemolyticus, isolated from BU wounds could contribute to the delay in wound healing of 
patients as well (Amissah et al., 2015b). Consequently, without further studies on the expression 
of virulence factors of wound-resident S. aureus and other microorganisms, the role of S. aureus 
in potentially causing delay in wound healing is presumptive and needs to be proven in further 
research.
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In developing countries, hospitalized burn victims are at high risk of nosocomial infections 
caused by Staphylococcus aureus. Risk factors include poor infection control practices, prolonged 
hospitalisation and limited capacity for laboratory microbiological analyses. These problems are 
compounded by widespread use of antibiotics that drives the spread of multi-drug resistant 
bacteria.
Methods
During the study period (November 2014-June 2015), nasal and invasive S. aureus isolates were 
collected consecutively from patients and healthcare workers (HCWs) within the burn unit of the 
Reconstructive Plastic Surgery and Burn Center of Korle Bu Teaching Hospital in Ghana. Antibiotic 
prescription, antibiotic susceptibility and bacterial typing were used to assess antibiotic pressure, 
antibiotic resistance, and possible transmission events among patients and HCWs.
Results
Eighty S. aureus isolates were obtained from 37 of the 62 included burn patients and 13 of the 29 
HCWs. At admission, 50% of patients carried or were infected with S. aureus including methicillin 
resistant S. aureus (MRSA). Antibiotic use per 100 days of hospitalization was high (91.2 days), 
indicating high selective pressure for resistant pathogens. MRSA isolates obtained from 11 
patients and one HCW belonged to the same spa-type t928 and multi-locus sequence type 250, 
implying possible transmission events. A mortality rate of 24% was recorded over the time of 
admission in the burn unit.
Conclusion
This study revealed a high potential for MRSA outbreaks and emergence of resistant pathogens 
amongst burn patients due to lack of patient screening and extended empirical use of antibiotics. 
Our observations underscore the need to implement a system of antibiotic stewardship and 
infection prevention where microbiological diagnostics results are made available to physicians 
for timely and appropriate patient treatment.
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Introduction
Burns are a major public health problem globally, but this problem is especially grave in low- and 
middle-income countries (LMIC). Burns in LMIC lead to high mortality rates of over 95% and the 
survivors frequently suffer from lifelong disabilities [1].
In sub-Saharan Africa, prevention and management of burns receive limited attention.  The 
general public lacks knowledge on prevention and first aid [2,3], and 84% of burns occur in 
children below the age of ten years [4]. The few burn units available are frequently inadequately 
equipped and lack the needed multidisciplinary approach, including infection control programs 
[5–8]. Burns in sub-Saharan Africa are often related to the use of petroleum products, leading to an 
equal ratio of scalds to flame burns [4,9]. This is exemplified by a petroleum fire disaster in Ghana 
in 2015, which claimed about 200 lives in the southeastern part of the country (daily graphic, 2nd 
June 2015). Reliable data on burn victims’ mortality is difficult to obtain since people may die on 
the spot or when discharged from the hospital, and mortality rates cannot be interpreted without 
data on the Total Body Surface Affected (TBSA). A recent study, described a mortality rate of 13% 
in the burn patients who visited a university hospital in the middle part of Ghana [10].
Infections are common in burn patients and, in particular, invasive infections are responsible for 
28-65% of burn deaths worldwide [11,12]. Staphylococcus aureus is an opportunistic pathogen 
that causes skin and soft tissue infections as well as invasive infection in burn patients. In a South 
African intensive care burn unit,  methicillin  resistant S. aureus (MRSA) was the third most common 
organism encountered in blood cultures. In this setting 17% of the patients with MRSA-positive 
blood cultures died [13]. In addition, invasive infections caused by Acinetobacter baumannii and 
Pseudomonas aeruginosa were found to frequently lead to death of burn patients.
Recently, studies on S. aureus genetic diversity in healthcare and community settings have 
detected spa-types t084, t314 and t355 to be predominant in Ghana [14–18]. However, there has 
so far been no data published on the prevalence of S. aureus and this pathogen’s association with 
invasive infections in burn centers in Ghana. The present study was therefore aimed at assessing 
the epidemiology of S. aureus in burn patients in the Reconstructive Plastic Surgery and Burn 
Center of the Korle Bu Teaching Hospital (KBTH), Korle Bu, Ghana, during a seven-month survey. 
Burn patients and healthcare workers (HCWs) were screened for S. aureus, and the antibiotic 
resistance profiles of nasal or invasive S. aureus isolates were investigated. Data from this study is 
intended to guide future antimicrobial therapy and effective hospital infection control.
Materials and Methods
The burn unit of the Reconstructive Plastic Surgery and Burn Center of KBTH records about 328 
admissions per year with about 27% in-hospital mortality. All burn patients are referred from 
either the intensive care unit (ICU) of the hospital or from other regional or district hospitals in the 
country. Patients are referred based on the severity of the burns, the surgical intervention needed, 
and sometimes for logistical reasons. The burn unit comprises six beds each in the adult male 
and female wards, seven beds in the children’s ward and two beds in the isolation ward. The unit 
has an operating theater and a treatment/dressing room. Wounds of burn patients are cleaned 
with water containing antiseptic solution (cetrimide 3% w/v and chlorhexidine gluconate 0.3% 
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w/v). The wounds are subsequently rinsed with normal saline and topical ointments containing 
antiseptics. Silver sulphadiazine and sulphadiazine are applied onto the burn wound. This is 
followed by an occlusive dressing with paraffin-soaked gauze, sterile cotton and a bandage. The 
dressings are changed every 72 hours.
Study participants
Following ethical clearance from the ethics committee of the Noguchi Memorial Institute for 
Medical Research (FEDERAL WIDE ASSURANCE FWA 00001824), patients’ and HCWs data and 
samples were collected for the present study. All samples were collected upon written informed 
consent or assent from all participants aged ≥ 12 years, and consent from a parent, caretaker, or 
legal representative of any participant below the age of 18 years.
All patients consecutively admitted to the burn unit of the Reconstructive Plastic Surgery and 
Burn Center of KBTH, Ghana, from November 2014 to May 2015 were invited to participate. 
General patient information including age, gender, type of injury, length of stay, outcome (death 
or discharge), TBSA and use of antibiotics were retrieved from the patients’  files. However, patients’ 
data from the referral centres prior to admission in this burn unit was unavailable. Antibiotic 
consumption was expressed as the total number of days of antimicrobial use per total number 
of admission days.
Specifically, both nares and wounds were swabbed using dry eSwabs, which were subsequently 
suspended in 1 ml liquid Amies medium (Copan Diagnostics Inc., Murrieta, CA, USA). Blood 
cultures were collected  from the patients upon  admission in the burn unit and biweekly during 
the change of wound dressings. Blood cultures testing positive for S. aureus, or MRSA carriage 
were reported to the responsible clinician to ensure appropriate clinical management. Nasal 
swabs were collected from healthcare workers once per two months for the duration of the seven 
months study period.
Bacterial isolation, identification, mecA detection and antimicrobial susceptibility testing
All swabs were streaked on 5% sheep blood agar (BA) and the respective plates were incubated 
at 37˚C overnight. Presumptive S. aureus colonies were tested for coagulase using the Pastorex 
Staph Plus test (Bio-rad, Marnes-la-Coquette, France) and nuc PCR [19]. S. aureus isolates were 
confirmed using matrix-assisted laser desorption ionization- time of flight mass spectrometry 
(MALDI-TOF MS) with a microflex LT Biotyper (Bruker Daltonics, Bremen, Germany) according to 
manufacturer’s instructions.
Blood cultures collected biweekly from patients were incubated in the BACTEC-9240 blood 
culture system (Becton Dickinson, Sparks, MD, USA) for seven days. Cultures were made from blood 
samples that gave positive signals for identification of S. aureus as described previously. To identify 
MRSA, all S. aureus isolates were screened for mecA gene as previously described [20]. Antimicrobial 
susceptibility testing of S. aureus was initially performed using the disk diffusion method on Muller 
Hinton Agar and interpreted according to the CLSI guidelines at Noguchi Memorial Institute for 
Medical Research in Ghana [21]. These analyses were, however, only performed on the S. aureus 
isolates from the nares and wounds of patients and/or HCWs that tested positive for the mecA 
gene, and for the methicillin sensitive S. aureus (MSSA) and MRSA isolates from invasive infections. 
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Antimicrobial susceptibility testing was further performed on all S. aureus isolates with the VITEK 2 
system (AST-P633, bioMerieux Corporate, Marcy l’Etoile, France) according to the manufacturer’s 
instructions at the diagnostics  laboratory of the University Medical Center Groningen in the 
Netherlands. The used cards contained the following antibiotics: benzylpenicillin, cefoxitin, 
chloramphenicol, ciprofloxacin, clindamycin, erythromycin, fosfomycin, fusidic acid, gentamicin, 
kanamycin, linezolid, mupirocin, oxacillin, rifampicin, teicoplanin, tetracycline, tobramycin, 
trimethoprim/sulfamethoxazole and vancomycin. The minimum inhibitory concentration results 
were interpreted according to EUCAST guidelines (www.eucast.org).
Detection of the Panton-Valentine leukocidin genes and bacterial typing 
All S. aureus isolates were screened for the presence of Panton Valentine Leucocidin (PVL) by 
PCR as previously described [22]. Spa-typing of S. aureus isolates was performed as previously 
described by Harmsen et al. [23]. DNA sequences were determined using an ABI Prism 3130 
genetic analyser (Applied Biosystems, Foster City, USA). Spa-types were assigned using the Ridom 
Staph Type software version 2.2.1 (Ridom GmbH, Würzburg, Germany) [23]. Multilocus Sequence 
Typing (MLST) was performed on a subset of isolates (n = 70) as described by Enright et al. [24].
Statistical analysis
Descriptive statistics including median and inter-quartile range (25-75%) were used for quantitative 
data (age, TBSA of the burn injury, and length of hospital stay). The association between patients’ 
characteristics and the carriage of S. aureus was calculated using Pearson chi-square or Fisher’s 
exact test and Mann-Whitney U test as appropriate. Statistical analysis was performed with SPSS 
22.0 (SPSS Inc., Chicago, IL) software.
Results
Patient characteristics
Sixty-seven patients were admitted to the burn unit during the study period. Sixty-two patients 
were recruited while five patients declined participation. The patients were referred from 20 
hospitals (n = 26) in Ghana and the ICU of the KBTH (n = 36). General patient characteristics are 
presented in Table 1.  The median  age  was 25  years  (IQR: 3 - 35) and 36% of the participants were 
younger than 10 years. Flames accounted for the cause of burns for the majority of the patients. 
The median TBSA of the burn was 15% (IQR: 7.8 – 28.2%).
Twenty-nine HCWs (resident (n = 1), house officer (n = 1), nurses (n = 30) and cleaners (n = 2)) 
were included during the study period. Twenty-four HCWs completed the study; the other HCWs 
were transferred to other units within the hospital. Twenty-nine HCWs were swabbed on each 
occasion including newly transferred HCWs. None of the HCWs declined participation during the 
study.
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Table 1. Patient characteristics. 
 
Patient characteristics Number (IQR or % 
frequency) 
Sex (female, percentage) 37 (60%) 
Age (years, median (IQR)) 25 (3-35) 
Type of burn 
 
Acid 1 (1.6%) 
Chemicals 2 (3.2%) 
Electrical 1 (1.6%) 
Flame 24 (38.7%) 
Gas 16 (25.8%) 
Scald (hot fluids) 18 (29%) 
TBSA (median %) 15 (7.8- 28.2) 
Hospital stay (days)* 11 (5- 17.5 ) 
In-hospital mortality 15 (24.2%) 
*Hospital stay refers exclusively to hospitalization in the burn unit 
	
Table 1. Patient characteristics
*Hospital stay refers exclusively to hospitalization in the burn unit
S. aureus epidemiology in the burn unit
Eighty S. aureus isolates were obtained from 37 (60%) of the 62 patients and 13 (45%) of the 29 
HCWs. Twenty-two (28%) isolates tested positive for the mecA gene. On the first day of admission 
(within 24 hours) 31 (50%) patients carried at least one S. aureus strain in their nares (n = 21), burn 
wounds (n = 17), or both (n = 9). Four patients had S. aureus detected in their blood culture. Two 
of these patients carried S. aureus in their nares and burn wounds simultaneously. Seven (11%) 
of the 62 patients tested MRSA-positive on the first day of admission, two of whom had MRSA 
detected in their blood cultures. Four of these seven MRSA-positive patients were referred from 
the KBTH ICU and three from one of the other referral centers. In eight (13%) of the 62 patients 
S. aureus was cultured after the admission. These eight patients carried at least one strain in their 
nares (n = 5), burn wounds (n = 5) or both (n = 3). In five of these eight patients the acquired S. 
aureus strain was MRSA.
Thirteen (45%) of the 29 HCWs tested positive at least once with S. aureus during the study period. 
One of the HCWs carried MRSA.
Antibiotic prescription and S. aureus resistance pattern
Cefuroxime was one of the antibiotics frequently consumed by burn patients. Further use of 
antimicrobials was triggered by clinical events (fever or suspected sepsis) or - in a minority of 
cases - by the detection of S. aureus invasive infections and sometimes MRSA wound colonization 
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Table 2. Number of days of antibiotics prescribed per 100 days in the burn unit and 
antibiotic resistances of the 80 investigated S. aureus isolates. 
 
Antibiotics Number of days 
of antibiotic used 
per 100 in-patient 
hospital days 
No. (resistance rate %) 
Amoxicillin-clavulanic acid 1.9 - 
Cefuroxime 60.6 - 
Ceftazidime 1.6 - 
Benzylpenicillin - 80 (100) 
Oxacillin - 22 (28) 
Vancomycin 0.4 0 (0) 
Gentamicin 11.9 21 (26) 
Tobramycin - 21 (26) 
Kanamycin - 22 (28) 
Ciprofloxacin 5.6 21 (26) 
Levofloxacin 4.1 - 
Chloramphenicol - 35 (44) 
Clindamycin - 1 (1) 
Erythromycin 2.3 1 (1) 
Fosfomycin - 0 (0) 
Fusidic acid - 0 (0) 
Mupirocin - 0 (0) 
Linezolid - 0 (0) 
Teicoplanin - 0 (0) 
Rifampicin - 1 (1) 
Tetracycline - 41 (51) 
Trimethoprim/sulfamethoxazole - 20 (25) 
Metronidazole 2.9 - 





during the current study. The antibiotics prescribed in the burn unit during the study period are 
presented in Table 2.
All 80 S. aureus isolates were tested for susceptibility to antibiotics. The results are presented in Table 
2. None of the isolates were resistant to fosfomycin, fusidic acid, linezolid, mupirocin, teicoplanin, 
or vancomycin. On the other hand, all isolates were resistant to benzylpenicillin and over half 
of the isolates (51%) were resistant to tetracycline. Twenty-two (28%) isolates were resistant to 
cefoxitin and oxacillin, and 21 of these isolates from 11 patients and one HCW displayed a similar 
antibiotic resistance pattern to gentamicin, kanamycin, tobramycin and ciprofloxacin (S1 Table).
Table 2. Number of days of antibiotics prescribed per 100 days in the burn unit and antibiotic resistances of the 80 
investigated S. aureus isolates
“-” indicates that antibiotics were not prescribed to burn patients or that the resistance of S. aureus to the respective 
antibiotics was not tested.
Epidemiology of Staphylococcus aureus in a burn unit of a tertiary care center in Ghana
5
514537-L-bw-Amissah
Processed on: 17-10-2017 PDF page: 80
 80 
Table 3. Antibiotic resistance profiles and detection of PVL genes in S. aureus 
isolates with different spa-types. 
 




t008 8, 2021 5 Ben 0 
t024 8 1 Ben 0 
t084 15, 3249, - 10 Ben, tri/sulf 7 
t127 1, 3248 5 Ben 0 
t1816 15 3 Ben, tri/sulf 2 
t2055 2434 1 Ben, tet, chl, 
tri/sulf 
0 
t304 6 1 Ben 0 
t311 5 2 Ben, tet, chl, 
rif, tri/sulf 
0 
t314 121 2 Ben, tet, 
tri/sulf 
2 
t355 152 8 Ben, chl 7 
t5132 508 1 Ben 1 
t537 3251 5 Ben, tet 3 
t645 3250 4 Ben 4 
t827 508 2 Ben, tri/sulf 0 
t8453 508 1 Ben, tri/sulf 0 
t861 508 3 Ben 0 
t8860 45 1 Ben 0 
t928 250 21 Ben, oxa, gen, 
kan, tob, cip, 
tet, chl 
0 
t939 45 1 Ben 0 
t963 15 3 Ben 1 
Ben- benzylpenicillin, oxa- oxacillin, gen- gentamicin, kan- kanamycin, tob- tobramycin, cip- 
ciprofloxacin, tet- tetracycline, chl- chloramphenicol, rif- rifampicin, tri/sulf- 
Trimethoprim/sulfamethoxazole. The “-” indicates that an isolate was untypable by MLST. n/a 




Detection of PVL genes and bacterial-typing
PVL-encoding genes were detected in 27 (34%) of the 80 isolates obtained from 17  (27%) of the 
62 patients (anterior nares [n = 6] and wound [n = 12]) and 6 (21%) of the 29 HCWs. S. aureus 
isolates from patients and HCWs were assigned 20 different spa-types and 16 STs including four 
new STs: ST3248, ST3249, ST3250, ST3251 and one untypable isolate (Table 3, S1 Table). S. aureus 
with the spa-types t008, t084, t127, t2055, t304, t311, t5132, t645, t827, t8453 (MSSA) and t928 
(MRSA) were obtained  from the nares of patients. S. aureus obtained from wound swabs of 
patients belonged to spa-types t084, t311, t314, t355, t537, t645, and t939 (MSSA), and t008 and 
t928 (MRSA) (S1 Table). In the case of five patients, this may suggest autoinoculation from the 
nares to wound or vice versa. The spa-types t127, t355, t861, t8860 (MSSA) and t928 (MRSA) were 
identified in S. aureus invasive infections. S. aureus carriage by HCWs was identified as MSSA (t008, 
t024, t084, t127, t1816, t861 and t963) and MRSA (t928), and most HCWs carried S. aureus with the 
same genotype on more than one occasion. Interestingly, 21 of the 22 MRSA isolates belonged 
to the spa-type t928 (ST250) while the other MRSA isolate belonged to spa-type t008 (ST8). The 
MRSA isolates with spa-type t928 were cultured from 11 patients and one HCW.
Table 3. Antibiotic resistance profiles and detection of PVL genes in S. aureus isolates with different spa-types
Ben- benzylpenicillin, oxa- oxacillin, gen- gentamicin, kan- kanamycin, tob- tobramycin, cip- ciprofloxacin, tet- 
tetracycline, chl- chloramphenicol, rif- rifampicin, tri/sulf- Trimethoprim/sulfamethoxazole. The “-” indicates that 
an isolate was untypable by MLST. n/a indicates that MLST was not performed.
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Table 4. Carriage of or infection with S. aureus at least once during 
admission of patients. 
 
 
S. aureus at least 
once (positive) 
No S. aureus p-value 
Age (years) 26 25 0.57* 
TBSA (median %) 15 16.5 0.83* 
Sex: female (%) 18 (66%) 19 (54%) 0.32# 
Mortality rate 5 (18.5%) 10 (28%) (RR 0.59; 0.25- 
1.42) 
*, Mann-Whitney U Test used for analysis 
#, Pearson, chi-square used for analysis 





S. aureus invasive infection
S. aureus was detected in the blood cultures during the biweekly routine samplings in six (10%) 
of the 62 patients hospitalized. On the first day of admission, 4 (6%) patients already had blood 
cultures positive with S. aureus. Seven S. aureus isolates were  obtained from the blood cultures 
of the six patients. Three of these isolates were MRSA (t928), four were MSSA (t127, t355, t861 and 
t8860) and all 7 isolates were PVL- negative (S1 Table). Physicians received the results including the 
antibiotic susceptibility pattern to treat patients for invasive infection. Patients with MRSA invasive 
infection were treated by the attending physicians with either erythromycin or vancomycin 
while patients with MSSA invasive infection were treated with erythromycin, gentamicin or 
ciprofloxacin. However, the therapy was sometimes changed from vancomycin to erythromycin, 
because patients could not afford vancomycin treatment.
In-hospital mortality
A mortality rate of 24% during the admission at the burn unit was recorded. Half of the patients 
with a TBSA of 19% or more died during the admission (LD50 of 19%). Patients who died were 
in the hospital for a median of 9 days (IQR: 2 - 42). None of the patients with S. aureus detected 
in the blood culture died (RR 0.23; 0.01-3.87). Mortality in patients with S. aureus cultured at least 
once from wounds, blood or nares during the admission was 18.9%, whereas mortality in patients 
without S. aureus cultured during their admission was 32% (RR 0.59; 0.25-1.42) (Table 4).
Table 4. Carriage of or infection with S. aureus at least once during admission of patients
*, Mann-Whitney U Test used for analysis
#, Pearson, chi-square used for analysis 
RR, relative risk
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Discussion
The present study describes the S. aureus epidemiology in burn patients and HCWs in a burn 
unit in Ghana. To our knowledge, this is the first report of such data from Ghana. In developed 
countries, the elderly are often susceptible to burn injuries [25,26]. Our study describes a much 
younger patient group with burns, which is consistent with reports from other health centers in 
Ghana and other African countries, where children of 10 years and below represent the majority 
of burn victims [4,10]. Most of the burn patients suffered from flame burns (39%) due to the use 
of candles and kerosene lamps for lighting as a result of the national electricity crisis in Ghana.
Referrals from the 20 hospitals and the ICU of the KBTH were often made due to the worsening 
conditions of patients, lack of resources or skilled professionals for specialized care of third degree 
burns, or logistical reasons. Routine screening of patients for MRSA carriage or multi-drug resistant 
organisms (MDRO) are not performed in the burn unit. Here, infection control measures were 
taken with regard to only one MRSA patient, which indicates the high risk of patient-to-patient 
transmission events. Interestingly, the MRSA cases included patients who tested positive on the 
day of admission and patients who acquired the MRSA during admission. The majority of these 
isolates (21 of 22) were shown to belong to the spa-type t928 and ST250. Thus, patients that 
tested positive on admission could be the possible source of the nosocomial MRSA transmission 
events. This observation highlights the need for implementing infection control and prevention 
measures in referring health care centers to prevent outbreaks of disease that currently remain 
unnoticed. Previous studies have shown that colonized but non-isolated patients increase the 
risk for nosocomial transmission events [27,28]. Since most presently identified MRSA cases were 
referrals, it is important that patients from referral centers that frequently report MRSA, such as the 
KBTH ICU, be screened for MRSA when transferred to the burn unit to prevent possible outbreaks. 
Further, almost half of the HCWs (45%) were transient carriers of S. aureus, including MRSA, which 
indicates their possible involvement in nosocomial transmission events in the burn unit. S. aureus 
carriage of 23% among HCWs in other departments in this hospital has been reported [29]. In this 
respect, it should be noted that bacterial typing methods, such as spa-typing and MLST, are not 
optimal for inferring nosocomial events, because they have a relatively low discriminatory power 
compared to whole genome sequencing. Therefore, whole genome sequencing analyses of the 
MRSA isolates (ST250) will be needed to confirm such events.
The high incidence of MRSA isolates with ST250 is noteworthy. First reported as the cause of 
epidemic MRSA disease and dominant MRSA genotype in the mid-1960s in Australia, Europe 
(Denmark, Germany, Switzerland), Uganda and the United Kingdom, and during the 1970s-1980s 
in Ireland [30–32], there are presently no reports of ST250-I MRSA in these regions [31]. Recently, 
ST250-I MRSA has, however, emerged in skin and soft tissue infections in a health care center in 
Ghana [14]. Further, our present data shows a wider distribution of ST250-MRSA with the SCCmec 
type IV variant from other referral health care centers in Ghana suggesting the rapid dissemination 
of this strain in hospitals of this country.
The overall use of antibiotics per 100 in-patient hospital days was observed to be high due to 
the extended use of empirical treatment and lack of microbiological diagnostic results. Clinical 
isolates obtained from burn patients have been reported to be resistant to commonly prescribed 
drugs in burn units [33–35]. Thus, appropriate prescription of antibiotics is important to prevent 
emergence of resistant bacteria. However, this can only be achieved if the burn units are equipped 
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with some baseline epidemiological and microbiological data.
We observed a 27% of carriage of PVL-positive S. aureus in burn patients. PVL-positive MRSA was 
not detected in this study. PVL-positive MRSA has been reported in burn centers in the United 
Kingdom (9%), United States of America (2.5%) and Iran (7%) [36–38]. Additionally, none of 
the S. aureus isolates from invasive infections carried the PVL gene. This is remarkable as, more 
frequently, S. aureus isolates from invasive infections have been reported to carry PVL-encoding 
genes in Ghana and the Democratic Republic of the Congo (49-75%) [18,39]. Here, it should be 
mentioned that the major S. aureus spa-types t084, t355 and t928 identified in our study have 
been described previously in Ghana [14–18].
The mortality rate (24%) recorded in our study was within the range (9 - 27%) reported by burn 
centers in other sub-Saharan African countries [4]. We observed 100% mortality in patients with 
TBSA burns greater than 40% [40,41]. The lethal Dose 50 (the percent TBSA at which 50% of 
patient survive) is a measure of the quality of care given to burn patients. In the present study, 
half of the patients with a TBSA of 19% died during the admission, indicating that burns with 
such a relatively small size lead to poor clinical outcomes in Ghana. This contrasts with settings in 
more affluent countries, where therapeutic advancement in burn care has increased the LD50 to 
25-77% [25,42,43].
The lower mortality rate observed in patients carrying and/or infected with S. aureus was a 
surprising finding. However, this may be explained by the accessibility of the microbiological 
diagnostic results and timely and appropriate treatment of patients during the study period. 
Further diagnostics on bacteria other than S. aureus were not performed. This lack of screening 
for microorganisms other than S. aureus that nonetheless are commonly involved in infectious 
complications of burn wounds is a limitation to this study. Gram-negative bacteria such as 
Pseudomonas aeruginosa and Acinetobacter baumannii have been reported to frequently cause 
nosocomial infections in burn patients and may have antimicrobial resistance patterns severely 
limiting the treatment options in this health care setting [44–47]. Of note, hospital hygiene 
measures in the burn unit were not assessed in the present study. Previous studies have reported 
low compliance of hand hygiene by health personnel [48–50] and high  prevalence of pathogenic 
bacteria on surfaces of operating theaters, door handles, desktops and lavatories in health care 
settings in Ghana [51].
In conclusion, our study shows that it is very well possible that MRSA outbreaks occur unnoticed 
in the presently investigated burn unit. This is highly worrisome as this burn unit is representative 
for the situation in many sub-Saharan burn units. Although this has not become directly evident 
from our study, improving the capacity for microbiological diagnostics and antibiotic stewardship 
will most likely reduce the mortality rate in such burn units by optimizing the use of antimicrobials 
and earlier detection of outbreaks of highly drug resistant pathogens.
Supporting information legend
S1 Table. S. aureus isolates from burn patients and healthcare workers.
“-” and empty cells under the ST column indicate that isolate was untypable and MLST was not 
performed for these isolates respectively. 
https://doi.org/10.1371/journal.pone.0181072.s001
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Staphylococcus aureus infections in burn patients can lead to serious complications and death. 
The frequency of S. aureus infection is higher in low and middle-income countries due to limited 
resources, misuse of antibiotics and poor  infection control practices.
Methods
S. aureus surveillance was performed amongst burn patients and healthcare workers (HCWs) during 
a seven-month survey (November 2014-June 2015) within the burn unit of the Reconstructive 
Plastic Surgery and Burn Center of Korle Bu Teaching Hospital in Ghana. Here, we used population 
genomics to infer transmission events  and to examine antibiotic resistance among 66 isolates 
obtained from patients and HCWs.
Results
The 66 study isolates (59 colonizing and 7 clinical) were obtained from 31 patients and 10 HCWs. 
21 of these isolates were ST250-IV methicillin-resistant S. aureus (MRSA). Notably, 25 (81%) of 
the 31 patients carried or were infected with S. aureus within 24 hours of admission. Genome 
comparisons revealed six distinct S. aureus clones circulating in the burn unit, four of which 
comprised isolates from patients and HCWs. In particular, the core SNP difference between a 
colonizing isolate from the wound of a patient and an isolate from the nares of a HCW within 
the ST250-IV clone was 9, suggesting transmission events. Isolates exhibited a wide range of 
genotypic resistances  to antibiotics, including aminoglycosides (33%), chloramphenicol (50%), 
trimethoprim (21%), oxacillin (33%), fluoroquinolones (100%) and tetracycline (59%).
Conclusion
Genomics uncovered likely events of MRSA transmission within the investigated burn unit and 
detected multiple antibiotic resistant S. aureus. These results underscore the need to ensure that 
infection control best practice be followed, and to implement a bacterial typing method with 
high discriminatory power to identify possible MRSA outbreaks.
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Introduction
In sub-Saharan Africa, burn injuries are common and, compared to high-income countries, 
mortality is increased even after correction for the Total Body Surface Affected (TBSA). This is 
reflected by the size of burn that causes a 50% mortality rate (the lethal dose of burn injury where 
50% of the burn patients die (LD50)). Advances in burn care have improved the percentage of 
TBSA (77-99%) at which LD50 occurs in more affluent industrialised countries (Branski et al., 2009; 
Ellison, 2013; Jeschke et al., 2016; Khashaba et al., 2012; Kraft et al., 2012) compared to 19-39% for 
burn injury victims in sub-Saharan Africa (Amissah et al., 2017b; Tyson et al., 2013). In particular, 
nosocomial infections pose a significant challenge to the care for burn patients in developing 
countries. As shown in a recent study in Ghana, the overuse and general misuse of antibiotics 
combined with lapses in infection control largely contribute to the poor clinical outcomes in burn 
patients (Amissah et al., 2017a). The situation is exacerbated by resource limitations, which make it 
difficult to maintain hospital hygiene measures and to rapidly detect and treat infections.
Burn wounds are frequently colonized by microorganisms, such as Staphylococcus aureus, 
Pseudomonas aeruginosa, Acinetobacter baumannii, Candida spp., Aspergillus spp., and Fusarium 
spp. (Branski et al., 2009; Devrim et al., 2017). This is exemplified by studies where between 66–76% 
of patients’ burn wounds were found to be colonized by S. aureus within 2-7 days of admission 
in the hospital (Alaghehbandan et al., 2012; Taneja et al., 2013). Colonization with S. aureus was 
associated with increased TBSA, delayed wound healing, and prolonged hospitalization (Kooistra-
Smid et al., 2004; Manson et al., 1992; Reardon et al., 1998). In this respect, the high level of 
antibiotic resistance in S. aureus is worrisome. Methicillin resistant S. aureus (MRSA) bloodstream 
infections are known for excess mortality and increased length of hospital stay (de Kraker et al., 
2011a, 2011b).
Unfortunately, there is only limited data available for MRSA carriage and infections in Africa. Of note, 
MRSA was the third most common organism found in blood cultures in a South African intensive 
care burn unit, where 17% of the patients with MRSA-positive blood cultures died (Bahemia et al., 
2015). We have recently shown that in a tertiary care hospital in Ghana, 19% of the investigated 
burn patients carried or were infected with MRSA. The MRSA isolates of these patients belonged 
to spa-type t928 and multi-locus sequence type (MLST) 250. Of note MRSA isolates with the same 
spa and MLST types were identified in 3% of the HCWs taking care of the burn patients (Amissah 
et al., 2017a). The MRSA isolates from patients and HCWs displayed identical antibiotic resistance 
patterns suggesting possible transmission events. Other studies in Africa reported nasal MRSA 
carriage rates of 13-18% among HCWs (Akoua Koffi et al., 2004; De Boeck et al., 2015; Shibabaw et 
al., 2014), and possible MRSA transmission events between patients and HCWs are known to occur 
(Ben Ayed et al., 2010; Conceição et al., 2014b). Importantly, bacterial typing methods, such as 
spa-typing and MLST, have a relatively low discriminatory power. The results obtained with these 
methods are, therefore, only indicative for nosocomial transmission events. Hard conclusions 
concerning MRSA transmission and hospital outbreaks can only be drawn from whole-genome 
sequencing (WGS). Therefore, the present study was aimed at comparing the previously collected 
MRSA ST250 isolates by WGS to pinpoint possible lines of transmission. Our results show that 
transmission had indeed occurred, and they highlight the importance of routine surveillance of 
MRSA in hospitals in resource-limited settings.
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Materials and Methods
A seven-month prospective survey of S. aureus transmission events was conducted at the burns 
unit of the Reconstructive Plastic Surgery and Burn Center of Korle Bu Teaching Hospital, Ghana, 
from November 2014 to May 2015. The burn unit has a 21-bed capacity for the management of 
patients with second and third degree burn injuries. During this period the burn unit received 
burn cases from the intensive care unit (ICU) of the hospital and 21 other hospitals in the country. 
Rigorous infection control measures were not implemented in the burn unit at the time of the 
study. Patient information, including age, gender, type of injury, length of stay, outcome (death or 
discharge), percentage of total body surface affected (TBSA) and use of antibiotics, was obtained 
from patient files. Patient data from the referral centres prior to admission to the burn unit was 
unavailable. Blood cultures, nose and wound swabs were collected from the patients upon 
admission and biweekly during change of wound dressing as previously described (Amissah 
et al., 2017a). Nasal swabs were collected from HCWs (doctors, nurses, cleaners) once per two 
months during the study period.
Ethical Statement
The ethical committee of the Noguchi Memorial Institute for Medical Research (NMIMR) (FEDERAL 
WIDE ASSURANCE FWA 00001824) approved the use of clinical samples and data from patients 
and HCWs for this investigation. All samples were collected upon written informed consent 
or assent from all participants aged ≥ 12 years, and consent from a parent, caretaker, or legal 
representative of any child participant below the age of 18 years.
Nosocomial transmission events of S. aureus
Transmission events in the burn unit were defined as transfer of S. aureus with the same MLST 
type (derived from genome sequence data) from a colonized or infected HCW/patient to another 
HCW/patient previously negative or positive for another MLST with a core SNP difference of ≤40 
(Golubchik et al., 2013; Price et al., 2014) and an overlap in hospital stay (burn unit). Phylogenetic 
analyses of sub-populations (based on sequence types) using the BAPS (Bayesian Analysis of 
Population Structure) were used to infer the directions of transmission events.
Microbiological and whole-genome sequencing analysis
A total of 66 S. aureus longitudinally collected isolates from 31 burn patients and 10 HCWs (Amissah 
et al., 2017a) were subcultured on 5% sheep blood agar and incubated at 37 °C overnight. 
Genomic DNA was extracted from S. aureus using the Ultraclean microbial DNA isolation kit (MO 
BIO laboratories, Inc., Carlsbad, California, USA) according to the manufacturers’ instructions. DNA 
libraries were prepared using the Nextera XT v2 kit (Illumina, San Diego, CA, USA), and sequenced 
on the Illumina platform using 2x250-bp chemistry. Sequence reads were submitted to the 
National Center for Biotechnology Information GenBank under the Bioproject ID PRJNA295807. 
The raw reads were assembled into contigs using spades 3.9.0 (Nurk et al., 2013) and mapped 
to the fully assembled chromosome of S. aureus COL (ST250) (chromosome: CP000046) using 
snippy v3.21. MLST and antibiotic resistance detection were undertaken with mlst v2.82 and 
abricate v0.5-dev3, respectively. Maximum likelihood Phylogenetic trees were generated using 
Chapter 6
514537-L-bw-Amissah
Processed on: 17-10-2017 PDF page: 93
93  
an alignment of core genome SNPs with FastTree v2 (Price et al., 2010) under the GTR model. Trees 
were visualized using FigTree v1.4.24.
Phylogenetic analyses of genetic populations
BAPS 6 (Bayesian Analysis of Population Structure) was used to cluster (a prior of 10 depth levels 
and a maximum of 20 clusters were specified) the DNA sequence data into genetic populations 
(Cheng et al., 2013). To increase the resolution, BAPS groups were further analysed with population-
specific S. aureus reference strains, to maximise the size of the core genome and increase the 
potential to detect more variants. The reference genomes of S. aureus COL (ST250) (Accession no. 
CP000046), S. aureus N315 (ST5) (Accession no. BA000018.3) and S. aureus CC45 (ST45) (Accession 
no. CP006044.1) were used for BAPS populations 2, 4 and 6, respectively. For BAPS populations 1, 3 
and 5, genetically close reference genomes were publicly unavailable and we, therefore, selected 
the best de novo assemblies (i.e. assemblies with the greatest N50 score) within each population 
to serve as references. Sequence types within BAPS populations suspected of being linked to 
nosocomial transmission events were further analysed.
Results
Whole genome sequence analysis
Sixty-six S. aureus isolates were obtained from multiple screens of 31 burn patients and 10 HCWs 
as previously described (Amissah et al., 2017a). The first swabs from patients were collected within 
24 hours of admission. At this time point, 25 (81%) of the 31 patients carried or were infected with 
S. aureus, 6 (19%) of which were shown to carry MRSA. Eight patients acquired S. aureus in the burn 
unit, and in five of these cases this concerned MRSA. Upon WGS of the 66 isolates, MLST analysis 
identified 16 STs, including four novel types (ST3248, ST3249, ST3250, ST3251) and one untypeable 
isolate (Figure 1). The predominant ST was ST250 MRSA. Further, these analyses revealed that one 
patient (i.e. patient 35) carried a ST6 S. aureus strain on admission and, subsequently, acquired two 
different S. aureus genotypes (ST250 and ST3251) during treatment in the burn unit.
Alignment of sequence reads for the 66 isolates against reference S. aureus COL defined a 2.2 
Mbp core genome (79.6%) and identified 102,904 core SNPs, which were used to generate a 
phylogenomic tree (Figure 1). Interestingly S. aureus isolates with ST8, ST15, ST152, ST250 and 
ST508 were obtained from both patients and HCWs. S. aureus isolates with ST5, ST45, ST3248, 
ST3250 and ST3251 were obtained from different patients. This was indicative of transmission 
events between HCWs and patients, and between patients.
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Figure 1. Distinct S. aureus populations circulating in the burn unit of Korle Bu Teaching Hospital
Maximum likelihood phylogeny based on core genome SNP analyses of the 66 S. aureus isolates compared to 
the reference strain S. aureus COL. The first letter(s) in the strain code represents the type of sample from patients 
and/or HCWs: (B) blood; (N) nose swab; (W) wound swab, and (HCW) nose swab. The following number refers 
to the isolate ID from patient or HCW. The third letter, (A) or (B), indicates whether more than one isolate was 
obtained per patient or HCW. The number after the hyphen indicates the date of sample collection. Furthermore, 
the figure shows the sequence type (ST), the BAPS cluster number (1 to 6), the origin of the isolate, and genotypic 
antibiotic resistances. AMN, aminoglycoside; gen, gentamicin; kan, kanamycin; tob, tobramycin; PEN, penicillin; 
OXA, oxacillin; CHL, chloramphenicol; TET, tetracycline; TRI, trimethoprim; ERY, erythromycin; CLI, clindamycin; RIF, 
rifampicin.
Detection of nosocomial transmission events within discrete S. aureus populations
A Bayesian analysis of the population structure with BAPS identified six distinct populations 
among the diverse collection of 66 S. aureus isolates (Figure 1). Four of these six populations (i.e. 
populations 1, 2, 3 and 6) comprised isolates from both HCWs and patients. The six identified 
populations were further analysed using genomes from specific clonal complexes as reference 
strains to maximise the ability to detect strain differences. Sequence types were identified within 
each population and transmission events within ST clones were further investigated. In what 
follows, we address possible nosocomial transmission events that were revealed in the S. aureus 
populations.
For BAPS population 1, sequence comparison (reference isolate W57_130515) among seven 
isolates that belonged to ST152 identified 429 core SNPs (among a core genome of 2.7Mbp). Within 
this population were isolates cultured from the nares of two HCWs, wounds of three patients and 
blood of one other patient. Interestingly, all four patients (i.e. patients 24, 49, 57 and 58) tested 
positive within 24 hours of admission (first screening) (Figure 2). Two patients were referred from 
the Korle Bu Teaching Hospital’s ICU (i.e. patients 49 and 57) and two from separate hospitals (i.e. 
patients 24 and 58). Here, it is likely all four patients acquired the ST152 S. aureus strain from their 
referral healthcare centers prior to admission to the burn unit. The two HCWs acquired the ST152 
strain at one point in time during the study period (Figure 2). This implies that upon introduction 
into the burn unit, the S. aureus ST152 strain was indirectly transmitted to HCWs, either through 
contaminated surfaces and fomites, or through other unidentified individuals.
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Figure 2. Tracing transmission events amongst burn patients and HCWs in BAPS cluster population 1 (S. aureus 
ST152)
Blue and green horizontal bars represent the length of stay (in weeks) of burn patients and HCWs, respectively, in 
the burn unit. The red vertical lines represent the time point at which patients or HCWs tested positive for ST152.
For BAPS population 2, sequence comparisons (S. aureus COL reference genome) identified 
1,729 core SNPs (among a core genome of 2.6 Mbp) among the 24 isolates that belonged to 
ST8 (n=2), ST250 (n=21) and ST2021 (n=1). ST250 and ST2021 are single locus variants of ST8 at 
locus yqiL and aroE respectively. Of note, this population was collected from two HCWs and 14 
patients. Twenty-two of the 24 isolates were MRSA (ST8 and ST250). Possible transmission events 
were investigated in detail amongst the ST8 and ST250 subpopulation. The ST8 subpopulation 
identified an MRSA from a patient who was colonized on admission and an MSSA from a HCW. The 
ST8 MRSA lacked the PVL genes and the arginine catabolic mobile element. The SNP difference 
between these two isolates was 1,048 core SNPs (among a core genome of 2.6 Mbp). This SNP 
difference argues against a possible direct in-hospital transmission event. Further, twenty- one 
S. aureus isolates obtained during longitudinal sampling from 11 patients (i.e. patients 1, 3, 5, 
12, 13, 21, 35, 43, 51, 55 and 62) and a HCW (HCW16) were identified as ST250. Alignment of 
these isolates against the reference genome of S. aureus COL (ST250) identified 85 core SNPs 
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(among a core genome of 2.6 Mbp) with SNP differences between individual pairs of isolates 
being ≤40. Interestingly, isolates from patients who were already colonised on admission were 
interspersed on the ST250 phylogenetic tree (Figure 3a) and clustered with isolates from patients 
who probably acquired the strain in the burn unit, suggesting multiple introductions and spread 
of ST250 into the unit. Further, multiple isolates from different sites (nose, wound and blood) 
and at different time points from individual patients served as a source of transmission to other 
patients. For example, isolates from group A (i.e. patients 5, 51, 55 and 62) differed by 23 core SNPs 
(among a core genome of 2.7 Mbp). All patients in group A initially resided in the adult female 
ward. However, patient 5 was transferred to the children’s ward after 2 weeks (Figure 3b). Patients 
55 and 62 were already colonized on the day of admission. Interestingly, the hospital stay of 
patient 51 overlapped with that of patients 55 and 62, while there was no direct epidemiological 
link between patient 5 and any of the patients in this group. It is nevertheless likely that patient 
51 acquired the ST250 strain from the patients already colonized. In the case of groups B and E, 
core SNP differences of six and eight were detected, respectively (among core genomes of 2.7 
Mbp). The hospital stays of these two patients overlapped at the time of discharge of patient 21 
and admission of patient 35. Notably, patient 21 tested positive (blood culture and wound) on 
admission and was treated before discharge. Patient 21 resided in the adult female ward for a 
week before being transferred to the isolation ward, while patient 35 resided in the male ward 
(Figure 3b). This may suggest that patient 35 obtained the strain indirectly from patient 21 (e.g. 
through fomites or the common dressing room used by both patients). The number of core SNP 
differences of isolates in group C (patients 5 and 12) was 29 (among a core genome of 2.7 Mbp) 
and stays of these patients overlapped in the children’s ward (Figure 3b). It is thus likely that 
both patients obtained the S. aureus strain from a common source or that patient 12 obtained 
the strain directly from patient 5 after being colonized from contaminated fomites in the adult 
female ward. In this case patient 12 acquired the strain first in the burn wound and subsequently 
contracted a blood stream infection. On the other hand, patient 35 was colonized with the ST250 
S. aureus strain that was highly related to the strain previously carried by HCW16 in group D. 
The core SNP differences among group D isolates was 9 (among a core genome of 2.7 Mbp) 
suggesting that HCW16 transferred the strain to patient 35, or that both participants obtained the 
strain from another common source. Unfortunately, patient 35 was still colonized with the ST250 
strain in the nares and wound upon discharge from the burn unit into the community (groups 
B and E). The hospital stay of patients in Group F (patients 1 (female ward) and 13 (male ward)) 
with a core SNP difference of 20 (among a core genome of 2.7 Mbp) did not overlap, suggesting 
that environmental contamination including air, a common dressing room or a non-screened 
HCW/patient may have been the source through which patient 13 acquired the ST250 strain. This 
explanation is plausible since patient 1 was already colonized upon admission and the patient still 
carried the strain when discharged from the burn unit.
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Figure 3. Tracing transmission events amongst burn patients and a HCW in BAPS cluster population 2 (S. aureus 
ST250)
(a) Blue and green horizontal bars represent the length of stay (in weeks) of burn patients and HCW, respectively, in 
the burn unit. The red vertical lines represent the time point at which patients or HCWs tested positive for ST250-IV 
MRSA. (b) Relative positions of burn patients in the female, male, children’s and isolation wards during their stay 
in the burn unit.
BAPS population 3 comprised S. aureus isolates from six HCWs and seven patients. These isolates 
belong to ST15 (n=9), ST2434 (n=1), ST3249 (n=1), and one untypeable strain (n=1). ST2434 
and ST3249 are single locus variants of ST15 at the glpF and pta loci, respectively. Sequence 
comparison (reference genome W22_020215) among isolates in this population identified 1,426 
core SNPs (among a core genome of 2.6 Mbp). The ST15 group included three patients (i.e. 
patients 22, 32 and 46) who were already colonized on admission and six HCWs (i.e. HCWs 1, 5, 
7, 11, 18 and 24) who acquired the ST15 strain at different point in time during the study period 
(Figure 4). Amongst this group, 772 core SNP differences (among a core genome of 2.6 Mbp) 
were identified. The SNP difference between isolates from patient 32 and HCW 11 was 492 core 
SNPs (among a core genome of 2.7 Mbp) indicating that transmission events are unlikely. The SNP 
difference between isolates from patient 46 and HCWs 5 and 18 was 16 core SNPs (among a core 
genome of 2.7 Mbp). Transmission events in this case could not be inferred because patient 46 
carried the ST15 isolate upon admission and the HCWs acquired the ST15 S. aureus strain prior to 
admission of patient 46. This suggests that the patient and HCWs may have acquired the strain 
from a common source outside the burn unit. The SNP difference between isolates from HCWs 
1 and 24 was 3 core SNPs (among a core genome of 2.7 Mbp), showing that these isolates are 
highly related. This implies that both HCWs were colonised from a common source or a HCW-to-
HCW transmission event.
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Figure 4. Tracing transmission events amongst burn patients in BAPS cluster population 3 (S. aureus ST15)
Blue and green horizontal bars represent the length of stay (in weeks) of burn patients and HCWs, respectively, in 
the burn unit. The red vertical lines represent the time point at which patients tested positive for ST15.
For BAPS population 4, S. aureus isolates were obtained from ten patients. These isolates belonged 
to ST1 (n=1), ST5 (n=2), ST6 (n=1), ST3248 (n=2) and ST3251 (n=5). ST3248 is a single locus variant 
of ST1 at the aroE locus, ST6 is locus variant of ST5 at the arcC and yqiL loci. ST3251 is a variant of 
ST3248 at the aroE, gmk, pta, tpi and yqiL loci. Sequence comparison (reference genome isolate 
N315 (ST5)) among isolates in this population identified 33,375 core SNPs (among a core genome 
of 2.5 Mbp). S. aureus isolates in the STs 1, 5, 6 and 3248 originated from patients 4, 26, 31, 34, 35 
and 57, who were already carriers or infected on admission. S. aureus isolates from five patients 
(i.e. patients 35, 42, 51, 54 and 62) that belonged to ST3251 had 136 core SNP differences (among 
a core genome of 2.6 Mbp). Here, patient 35 may have acquired the ST3251 S. aureus strain 
indirectly from the burn unit before the admission of the patients 42, 51, 54 and 62), who already 
carried these strains on admission. In any case, this rules out possible in hospital transmission 
events (data not shown).
BAPS population 5 included six S. aureus isolates from four patients. These isolates belonged to 
ST121 (n=2) and ST3250 (n=4), and 1,648 core SNPs (among a core genome of 2.7 Mbp) were 
identified after genome comparisons (reference genome isolate W08B_161214). The ST3250 is 
a single locus variant of ST121 at the yqiL locus. Three of the four patients already carried the 
respective strains on admission. Among the four ST3250 isolates, two were from a patient 58 
(nares and wound) and two from the wounds of patients 47 and 55 (Figure 5). Between these 
Chapter 6
514537-L-bw-Amissah
Processed on: 17-10-2017 PDF page: 101
101  
four isolates 12 core SNP differences (among a core genome of 2.7 Mbp) were found, indicating 
that they are highly related and most likely share a common source. The time at which patient 47 
had apparently acquired the ST3250 strain preceded the time of admission of patients 55 and 58. 
However, since patients 55 and 58 carried their ST3250 strains already upon admission, we cannot 
infer direct patient-to-patient transmission events in this case (Figure 5).
Figure 5. Tracing transmission events amongst burn patients in BAPS cluster population 5 (S. aureus ST3250)
Blue horizontal bars represent the length of stay (in weeks) of burn patients in the burn unit. The red vertical lines 
represent the time point at which patients tested positive for ST3250.
BAPS population 6 comprised five isolates from three patients and one HCW. These isolates 
belonged to ST45 (n=2) and ST508 (n=3) (data not shown). ST508 is a single locus variant of ST45 
at the aroE locus. Sequence comparison (reference genome CA-347 (ST45)) among these isolates 
identified 16,001 core SNPs (among a core genome of 2.6 Mbp). Between the two ST45 isolates 
from patients (i.e. patients 28 and 46) there were 890 core SNP differences (among a core genome 
of 2.6 Mbp) and the patients’ hospital stays did not overlap. This indicates that transmission events 
were unlikely. On the other hand, the three ST508 isolates that originated from patient 26 and 
HCW21 had 17 core SNP differences (among a core genome of 2.6 Mbp). Interestingly, patient 26 
was already infected with the ST508 strain on admission, while HCW21 acquired the strain around 
the time of admission of patient 26. This indicates a possible patient-to-HCW transmission event 
(data not shown).
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Detection of antimicrobial resistance genes
Antibiotics consumption in the burn unit was previously shown to be high and S. aureus isolates 
were resistant to some prescribed antibiotics including gentamicin, ciprofloxacin and erythromycin 
(Amissah et al., 2017a). Therefore, we assessed genotypic antibiotic resistances from the de novo 
assembled genomes of the 66 study isolates. The results are shown in Figure 1. All isolates that 
belonged to ST250 carried the aac(6’)-aph(2”) gene that encodes resistance to aminoglycosides 
(gentamicin, kanamycin and tobramycin). One isolate in the ST8 group contained the ant(6)-Ia 
and aph(3”)-III genes conferring resistance to the aminoglycoside kanamycin. Further, the ST250 
isolates carried the blaZ and mecA genes, the cat(pC221), and the tetK and tetM genes, which 
confer resistance to β-lactams (penicillin [100%] and oxacillin [33%]), chloramphenicol (50%) and 
tetracycline (59%) (Figure 1) respectively. A point mutation in the rpoB gene, encoding a histidine 
to asparagine conversion at amino acid position 481 that confers resistance to rifampicin (Aubry-
Damon et al., 1998), was detected in one isolate belonging to ST5. In one isolate that belonged 
to ST8 the mph(C) and msr(A) genes were found, which mediate resistance to macrolides 
(erythromycin and clindamycin). Lastly, the dfrG gene encoding trimethoprim resistance, and 
the biocide resistance gene norA were detected in 21% and 100% of the sequenced isolates, 
respectively.
Discussion
This study describes possible S. aureus transmission events in the burn unit of a tertiary care 
center in Ghana. MLST analysis of 66 isolates identified 16 STs including four new genotypes, with 
ST250 being the predominant genotype. Unsupervised Bayesian clustering grouped the isolates 
into six distinct populations, four of which were comprised of isolates from patients and HCWs. 
Most patients carried S. aureus on admission, and transmission events were confirmed in 25% of 
the cases in the burn unit.
The overall infected or carriage rate (81%) of patients with S. aureus on admission was high 
compared to 35% reported in other studies (Kaiser et al., 2011; Kooistra-Smid et al., 2004). This 
may have affected wound healing, as it has been shown that patients carrying S. aureus in the 
nares or throat on admission, are often eventually colonized with the same genotype in the burn 
wound (Kooistra-Smid et al., 2004).
The ST152 PVL-positive community-acquired methicillin susceptible S. aureus (CA- MSSA) is 
significantly predominant in Africa (Conceicao et al., 2015; Egyir et al., 2014; Eibach et al., 2017; 
Kraef et al., 2015; Ruimy et al., 2008; Shittu et al., 2012) and has been detected in skin lesions of 
Buruli ulcer patients (Amissah et al., 2015; Kpeli et al., 2016).
Consistent with these previous data, seven of the eight ST152 MSSA study isolates were PVL-
positive (Amissah et al., 2017a). In contrast, a few cases of ST152 PVL-positive community-acquired 
MRSA (CA-MRSA), responsible for skin and soft infections, were reported in Europe (Brauner et al., 
2013; Jappe et al., 2008; Katopodis et al., 2010; Krziwanek et al., 2011) and in Haiti (Rosenthal et al., 
2014). Since the PVL virulence factor is associated with necrotic skin lesion (Novick, 2003; Novick 
et al., 1993), carriage of ST152 PVL-positive MSSA in the wounds of burn patients may have health 
implications, such as delayed wound healing and could lead to invasive infection. In the present 
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The ST250 clone was the first reported cause of epidemic MRSA disease, and the dominant MRSA 
sequence type in the mid-1960s in Europe (Denmark, Germany, Switzerland and the United 
Kingdom), Uganda and Australia, and during the 1970s-1980s in Ireland (Enright et al., 2002; 
Lancashire et al., 2013; Shore et al., 2005). While there are currently no reports of MRSA with ST250 
in these regions (Enright et al., 2002), this MRSA type has recently emerged in skin and soft tissue 
infections in a health care center in Ghana (Egyir et al., 2014). Further, our previous data (Amissah 
et al., 2017a) showed a wider distribution of ST250-MRSA with the SCCmec IV variant (i.e. ST250-IV 
MRSA) from other referral health care centers in Ghana, suggesting the rapid dissemination of this 
strain. Our present study provides clear evidence for ST250-IV MRSA transmission events that had 
been suspected based on spa- and MLST-typing and antibiotic resistance profiles (Amissah et al., 
2017a). In addition, possible patient-to-patient and HCW-to-patient transmission routes could 
now be described based on the use of WGS. With the high number of ST250-IV MRSA-positive 
patients observed on admission, it seems likely that MRSA outbreaks can occur unnoticed in 
the investigated burn unit. In turn, this may result in prolonged patient stays, increased cost of 
treatment and even increased mortality rates. It is important to note that, unfortunately, infection 
control measures were not applied to most of the MRSA- positive patients. Only one of the 11 
patients was isolated and ST250-IV MRSA-positive patients (patients 1 and 35) were dismissed 
from the burn unit still being positive. In addition, MRSA transmission events occurred probably 
due to the transfer of the ST250-IV MRSA-carrying patient 5 from one ward to another ward. 
Retrospectively, it must be concluded that implementation of barrier precautions, such as patient 
isolation, would have been an appropriate approach to limit the unwanted transmission of MRSA 
with ST250 in the investigated burn unit. Of note, basic hand hygiene compliance by HCWs 
was observed, but their knowledge on infection prevention and control measures may have 
been limited. Also, important resources, such as hand hygiene stations, disinfecting hand rub 
and disposable towels were not available in the burn unit. This is in line with previous studies, 
which reported that hand hygiene compliance by healthcare personnel in Ghana is generally low 
(Owusu-Ofori et al., 2010; Yawson and Hesse, 2013).
Analyses of the ST15 and ST508 isolates identified possible HCW-to-HCW and patient-to- HCW 
transmission events that further emphases lapses in infection control measures. Notably, these 
isolates belong to major MSSA clones that have been detected in community and healthcare 
settings in humans and livestock in Africa (Conceicao et al., 2015; Conceição et al., 2014; Conceição 
T, Coelho C, Santos-Silva I, de Lencastre H, 2014; Egyir et al., 2014; Ghebremedhin et al., 2009; 
Schaumburg et al., 2015).
Despite the low core SNP differences among S. aureus ST3250 isolates from the three patients 
who carried them, we were unable to pinpoint possible patient-to-patient transmission events 
for these isolates. Hence alternative explanations for the identification of the highly similar ST3250 
isolates in the three patients could be that transmission may have occurred through visitors or 
contaminated fomites.
The spread of antibiotic resistant S. aureus, including MRSA, among burn patients is particularly 
worrisome and is an issue of major public health importance5. The high rates of antibiotic 
resistance nowadays observed in bacterial pathogens have, amongst others, been reported to 
correlate with the high use of antibiotics in healthcare institutions (Borg et al., 2010; Kim et al., 
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2013; Nakamura et al., 2012; Westh et al., 2004). Recently, we observed a high consumption of 
antibiotics by patients for empirical treatment in the investigated Ghanaian burn unit (Amissah 
et al., 2017a). This is an unwanted situation, and administering appropriate antibiotics at the right 
dosage will be helpful in preventing the emergence of highly resistant strains. Particularly in African 
countries like Ghana, where antibiotics are readily accessible in pharmacies, the emergence of 
antibiotic resistant S. aureus amongst burn patients may have been the consequence of this high 
consumption of antibiotics in the community.
While clear evidence for S. aureus transmission has been obtained, our study has nevertheless 
some limitations. MRSA carriage or infection upon admission was previously reported to be 
associated with prior hospitalization with a length of stay of ≥ 7 days and surgery within the 
past 6 months (Wibbenmeyer et al., 2010). Although referrals of patients were often made from 
the Korle Bu Teaching Hospital’s ICU, our study lacked patient data prior to their referral to the 
burn unit. Such patient data would have been informative in determining the risk factors that 
predisposed patients to MRSA carriage or infection already on admission. Secondly, the routes of 
acquisitions were elucidated for only two of the eight nosocomial transmission events observed 
in patients. In this study, we were unable to identify other possible sources of MRSA transmission, 
such as contaminated fomites or visitors, which could perhaps have explained the indirect S. 
aureus acquisition by patients whose hospital stays did not overlap.
In conclusion, our present investigations have unveiled the introduction of CA-MSSA including 
PVL-positive CA-MSSA and hospital-acquired MRSA previously dominant in Europe, as well 
as nosocomial S. aureus transmission events among patients and HCWs, in the burn unit of a 
tertiary health care center in Ghana. WGS thus demonstrates the importance of infection control 
measures and appropriate antibiotic stewardship. Clearly, the implementation of relatively cheap 
typing methods, such as multiple-locus variable number tandem repeat fingerprinting and spa-
typing, or antibiotic susceptibility testing, allow the monitoring of suspected MRSA outbreaks 
in health care centers of resource- limited countries like Ghana. Nonetheless, unambiguous 
identification of MRSA transmission events and outbreaks will require the more sophisticated 
WGS-based comparison of individual isolates.
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Summary
As outlined in Chapter 1, the focus of the research described in this PhD thesis was to investigate 
the genetic diversity and transmission events of Staphylococcus aureus in BU and burn patients, 
and the virulence potential of S. aureus isolates from BU patients using molecular typing tools. 
Various molecular typing tools can be employed in the characterization of bacterial strains. In 
this PhD research project, the collected S. aureus isolates were characterized by a combination 
of multiple-locus variable number tandem repeat fingerprinting (MLVF), spa-typing and whole 
genome sequencing (WGS).
Chapter 2 addressed the diversity of S. aureus isolates from Ghanaian BU patients. The results 
show that 63% of the investigated BU patients were colonized with S. aureus at least once. MLVF 
analysis grouped 91 S. aureus isolates into 13 clusters. Four of the 13 clusters comprised isolates 
from the anterior nares and wounds of individual patients suggesting autoinoculation from 
the nose to the wound or vice versa. Further,  two clusters contained S. aureus isolates from the 
wounds of different patients that indicated possible transmission events among patients. With 
regards to the bacterial topography of BU wounds, we observed two S. aureus genotypes at one 
time point and temporal changes in genotypes in wounds of some BU patients. Twelve (13%) of 
the 91 isolates obtained from five patients were MRSA, however, one of the isolates lacked the 
mecA and mecC genes suggesting unknown causes for cefoxitin and oxacillin resistance. Lastly, 
79% of S. aureus isolates were positive for the pore-forming toxin, PVL.
Chapter 3 describes a phylogenetic analysis (gene-by-gene) of WGS data of 21 S. aureus isolates 
from the study described in Chapter 2. The aim of this WGS analysis was to confirm possible 
transmission events. The analysis grouped the respective isolates into 14 cluster types, which 
matched well with the typing results obtained by MLVF as described in Chapter 2. The MSSA 
(ST152) and MRSA (ST88) isolates from wounds of different patients were grouped into two 
clusters in accordance with their sequence types (ST), thereby confirming their transmission. 
Importantly, the transmission of these S. aureus isolates between patients is consistent with 
epidemiological data. Interestingly, investigated S. aureus isolates that belonged to ST88 and ST1 
contained a novel fexB allele that encoded resistance to chloramphenicol.
Chapter 4 documents the presence of different combinations of virulence factors such as 
exotoxins, enterotoxins and exfoliative toxins in sequenced S. aureus isolates from BU patients. 
Particular combinations of virulence genes were detected on mobile genetic elements (MGEs), 
including prophages, pathogenicity islands, genomic islands and the Staphylococcal cassette 
chromosome. The hla, hld, and psm genes were present in almost all isolates, but the expression 
of hemolysins was not detectable in all isolates. Intriguingly, seven novel SaPIs were detected. The 
identified virulence factors may enhance the survival and persistence of S. aureus in BU patients 
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Chapter 5 addresses the presence of S. aureus in wounds of Ghanaian patients with severe burns. 
The results show that 60% of the investigated patients and 45% of the investigated healthcare 
workers were carrying or infected with S. aureus at least once. Interestingly, almost half of the 
patients were already carrying S. aureus,  including MRSA (13%), on the first day of admission. 
A high consumption of cefuroxime (61%), gentamicin (12%) and ciprofloxacin (6%) per 100 in-
patient hospital days was observed in the burn unit. MRSA was detected in 19% of patients and 
3% of healthcare workers, and all MRSA isolates were resistant to ciprofloxacin, chloramphenicol, 
gentamicin, kanamycin, tetracycline and tobramycin. It seems likely that the high consumption 
of these antibiotics predisposes patients to resistant bacterial strains that no longer respond 
to antibiotic therapy. S. aureus invasive infection was detected in 10% of burn patients during 
routine blood culture. Lastly, a mortality rate of 24% was recorded for admitted patients, but this 
was not related with colonization or infection by S. aureus or MRSA.
In Chapter 6 the question was raised whether MRSA surveillance in burn units of Ghanaian 
hospitals is necessary. A phylogenetic analysis of WGS data and epidemiological analyses were 
performed to confirm possible MRSA transmission events in a burn unit. Interestingly, it was 
observed that MRSA isolates (ST250) from patients who were already colonized or infected at 
the time of admission clustered with isolates of newly colonized patients from the burn unit, 
suggesting possible transmission events. Here, different patients seem to have acted as the 
source of transmission to other patients. In addition, multiple isolates from an individual patient, 
which were collected at the same time or at different time points represented the source of 
transmission. Epidemiological data showed an overlap of some patients’ stay and involvement of 
a healthcare worker in the transmission pathway. Further, detailed analyses of antibiotic resistance 
genes showed similar patterns for isolates suspected of transmission events. Altogether, it is 
concluded that routine screening of S. aureus isolates from patients and healthcare workers using 
MLVF and WGS will be necessary to prevent, identify and control MRSA outbreaks in burn centers 
in resource-limited countries.
Lastly, Chapter 8 of this PhD thesis encompasses a brief General Discussion of the documented 
research outcomes plus some perspectives for future research and improved care for BU and 
burn patients in low-income countries such as Ghana.
Chapter 7
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Huidwonden zijn bijzonder vatbaar voor secundaire bacteriële infecties. Dit is met name 
een probleem in zorginstellingen met beperkte financiële middelen en een ontoereikende 
infectiepreventie. Het onderhavige promotieonderzoek had tot doel om de implicaties van 
bacteriële wondkolonisatie in een dergelijke setting te onderzoeken. Hiertoe werd specifiek 
de kolonisatie van zogenaamde Buruli ulcers (zweren) en brandwonden door de bacterie 
Staphylococcus aureus in Ghanese zorginstellingen bestudeerd. Buruli ulcer is een ernstige ziekte 
van de huid en onderhuidse weefsels die tot de Verwaarloosde Tropenziekten wordt gerekend 
en die wordt veroorzaakt door Mycobacterium ulcerans, een bacterie die verwant is aan de 
veroorzakers van tuberculose en lepra. Brandwonden behoren tot de ernstigste vormen van 
huidletsel en ~90% of van alle brandwonden komt voor in lagelonenlanden zoals Ghana. Buruli 
ulcers en brandwonden kunnen gekoloniseerd worden door vele soorten micro- organismen, 
waaronder de S. aureus bacterie die wondgenezing kan belemmeren.
Hoofdstuk 1 van dit proefschrift geeft essentiële achtergrondinformatie over de ziekte Buruli 
ulcer, de incidentie van brandwonden in lagelonenlanden zoals Ghana en de ernstige problemen 
die men aldaar ondervindt bij de behandeling en verzorging van Buruli ulcers en brandwonden. 
De aandacht is hierbij met name gericht op het centrale thema van het onderhavige 
promotieonderzoek, namelijk het in kaart brengen van de secundaire kolonisatie en infectie van 
de desbetreffende wonden door de S. aureus bacterie. S. aureus is een beruchte ziekteverwekker 
die zich erg thuis voelt in het wondmilieu en die de wondgenezing sterk kan vertragen. S. aureus is 
bovendien enorm goed in staat om resistent te worden tegen antibiotica, waardoor de bestrijding 
van S. aureus infecties vaak moeilijk is. Dit wordt onderstreept door de zogenaamde meticilline-
resistente S. aureus, beter bekend onder de naam MRSA. Om een goed overzicht te krijgen van de 
aard en omvang van de aanwezigheid van S. aureus in wonden van Ghanese patiënten met Buruli 
ulcers of brandwonden zijn in dit onderzoek geavanceerde technieken ingezet. Met name de 
sequentieanalyse van complete bacteriële genomen is zeer bruikbaar gebleken om de diversiteit 
van S. aureus in Buruli ulcers en brandwonden te bestuderen en om de mogelijke overdracht van 
S. aureus tussen patiënten en ziekenhuispersoneel aan te tonen.
Hoofdstuk 2 beschrijft de diversiteit onder S. aureus isolaten van Ghanese patiënten met Buruli 
ulcers. De resultaten laten zien, dat 63% van de onderzochte Buruli ulcer patiënten gekoloniseerd 
was door S. aureus. Met behulp van snelle DNA-typeringstechnieken konden de 91 verkregen 
S. aureus isolaten in 13 verschillende clusters gerangschikt worden. Vier van deze 13 clusters 
omvatten isolaten die afkomstig waren uit de neus en wonden van individuële patiënten. Dit lijkt 
te duiden op rechtstreekse bacteriële overdracht van de neus naar de wond of vice versa. Twee 
andere clusters brachten de S. aureus isolaten uit wonden van verschillende patiënten bijeen, 
hetgeen suggereert dat deze S. aureus bacteriën van patiënt op patiënt waren overgedragen. 
Een analyse van de bacteriële ‘wondtopografie’ in Buruli ulcers liet zien, dat op enig moment 
meerdere S. aureus types in één wond aanwezig kunnen zijn en dat de aanwezigheid van deze 
bacteriën na verloop van tijd kan veranderen. Twaalf (13%) S. aureus isolaten die afkomstig waren 
van vijf verschillende patiënten bleken MRSA te zijn. Tenslotte bleek dat 79% van de S. aureus 
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isolaten de genen voor een belangrijke factor voor de aanvalskracht van de bacterie - het pore-
vormende toxine ‘Panton–Valentine Leukocidine’ (PVL) - bezitten. Dit toxine wordt door de S. 
aureus bacterie ingezet bij de huidkolonisatie en daaropvolgende infectie van onderliggende 
weefsels. Aanwezigheid van de PVL-genen in S. aureus moet daarom beschouwd worden als een 
potentieel risico voor serieuze infecties bij patiënten met Buruli ulcers.
Hoofdstuk 3 beschrijft de genoomsequentieanalyse en de daarop volgende fylogenetische 
analyse van 21 S. aureus isolaten uit het onderzoek beschreven in Hoofdstuk 2. Dit onderzoek 
had tot doel om de mogelijke overdracht van S. aureus onder patiënten met Buruli ulcers te 
bevestigen. De uitgevoerde genoomanalyses groepeerden de verschillende isolaten in 14 
clusters die goed overeenstemden met de meer globale typering, zoals beschreven in Hoofdstuk 
2. Meticilline-gevoelige S. aureus isolaten van het type ST152 en MRSA isolaten van het type ST88 
uit de wonden van verschillende patiënten werden conform hun verschillende types in twee 
clusters verdeeld, hetgeen de eerder vermoede overdracht van patiënt op patiënt bevestigde. In 
dit opzicht is het van belang, dat de resultaten van de genoomsequentieanalyses ook in goede 
overeenstemming waren met de beschikbare epidemiologische gegevens van de patiënten. Een 
interessante bijvangst van het onderzoek was de identificatie van een nieuw gen, dat aanleiding 
geeft voor resistentie tegen het antibioticum chloramfenicol.
Hoofdstuk 4 documenteert de aanwezigheid van genen voor verschillende virulentiefactoren 
in de S. aureus isolaten van Buruli ulcer patiënten. Dergelijke virulentiefactoren, waaronder 
exotoxines, enterotoxines en exfoliatieve toxines, stellen S. aureus in staat om ziekte te veroorzaken 
door barrières van de huid, de slijmvliezen en het humane immuunsysteem te doorbreken. Dit 
onderzoek leidde met name tot het aantonen van de aanwezigheid van bepaalde combinaties 
van virulentie-genen op zogenaamde Mobiele Genetische Elementen (MGEs). Hieronder 
verstaat men stukken DNA die gemakkelijk overdraagbaar zijn tussen bacteriën onderling, 
zoals bijvoorbeeld het DNA van bacteriofagen, pathogeniciteitseilanden en het ‘Staphylococcal 
cassette chromosome’. Het laatstgenoemde MGE is karakteristiek voor de MRSA variant van S. 
aureus. Opmerkelijk was de waarneming dat bijna alle onderzochte S. aureus isolaten meerdere 
genen voor haemolysines bevatten die immuuncellen kunnen vernietigen, maar dat die 
genen in lang niet alle isolaten tot expressie kwamen. Verder werden maar liefst zeven nieuwe 
pathogeniciteitseilanden ontdekt, hetgeen het vermoeden bevestigt dat we nog erg weinig 
weten over de virulentiefactoren van S. aureus bacteriën in Afrikaanse landen zoals Ghana. Alle 
resultaten tezamen suggereren dat de geïdentificeerde virulentiefactoren het overleven van S. 
aureus bacteriën in Buruli ulcers mogelijk maken en dat ze wellicht verantwoordelijk zijn voor een 
vertraagde wondgenezing.
Hoofdstuk 5 beschrijft de aanwezigheid van S. aureus in wonden van Ghanese patiënten met 
ernstige brandwonden. Bij 60% van de onderzochte patiënten en bij 45% van het onderzochte 
ziekenhuispersoneel was de S. aureus bacterie aanwezig of veroorzaakte zelfs infectie. Opmerkelijk 
was, dat bijna de helft van alle patiënten al drager was van S. aureus, waaronder MRSA (13%), op 
de eerste dag van hun ziekenhuisopname. Het antibioticagebruik door de onderzochte patiënten 
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bleek erg hoog te zijn. Dit betrof met name de antibiotica cefuroxim (61%), gentamicine (12%) en 
ciprofloxacine (6%). MRSA werd ontdekt bij 19% van de patiënten en bij 3% van het verplegend 
personeel. Alle MRSA-isolaten bleken resistent tegen ciprofloxacine, chloramfenicol, gentamicine, 
kanamycine, tetracycline en tobramycine. Deze resultaten suggereren dat de hoge consumptie 
van deze antibiotica de brandwondenpatiënten min of meer voorbestemt voor kolonisering door 
resistente bacteriën die niet langer gevoelig zijn voor antibiotica. Door middel van bloedkweken 
bleek dat S. aureus diepe infecties veroorzaakt had bij 10% van de brandwondenpatiënten. 
Tenslotte werd een sterfte van 24% onder de opgenomen brandwondenpatiënten vastgesteld. 
Dit hoge sterftecijfer kon echter niet gerelateerd worden aan het dragerschap van, of infectie 
door S. aureus of MRSA.
Het onderzoek beschreven in Hoofdstuk 6 had tot doel om de vraag te beantwoorden of MRSA-
surveillance nodig is in brandwondencentra van Ghanese ziekenhuizen. Hiertoe werd een 
gecombineerde analyse van genoomsequenties en epidemiologische data uitgevoerd, om de 
mogelijke overdracht van MRSA in een Ghanees brandwondencentrum op te sporen. MRSA-
isolaten van het ST250 type die sommige patiënten reeds bij ziekenhuisopname bij zich droegen 
bleken vrijwel identiek te zijn aan MRSA-isolaten van patiënten die pas na hun ziekenhuisopname 
MRSA-positief werden. Dit is een sterke aanwijzing voor overdracht van MRSA tussen patiënten 
onderling, waarbij verschillende patiënten als mogelijke bron van de MRSA-overdracht 
aangewezen konden worden. Verder suggereren de resultaten van dit onderzoek betrokkenheid 
van ziekenhuispersoneel bij de overdracht van MRSA. Deze waarnemingen laten zien dat een 
routinematige screening van S. aureus isolaten van zowel patiënten als ziekenhuismedewerkers 
beslist noodzakelijk zal zijn om MRSA uitbraken te voorkomen, te identificeren en te beheersen in 
brandwondencentra in lagelonenlanden zoals Ghana.
Tenslotte omvatten de Hoofdstukken 7 en 8 respectievelijk een beknopte samenvatting van 
het onderzoek en een korte algemene discussie van de verkregen resultaten. De belangrijkste 
boodschap is, dat de resultaten van dit promotieonderzoek de noodzaak van adequate wondzorg, 
ziekenhuishygiëne en infectiepreventie aantonen. Juist in lagelonenlanden, zoals Ghana, is dit 
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Buruli ulcer (BU) and burn wounds cause high morbidity and mortality in low-income countries. 
Contamination of wounds in these settings results from poor hygienic and nutritional conditions, 
lack of adequate resources for wound care and insufficient infection control policies. Clearly, 
patients requiring extensive wound care under such under-privileged conditions, either due 
to BU or burns, are at risk of secondary infections that may cause delayed wound healing with 
increased suffering and an increased burden to health care as a result. A brief introduction to the 
topic of bacterial colonization of BU and burns, and the current situation in Ghana is presented in 
Chapter 1 of this thesis.
How diverse are the S. aureus isolates from Ghanaian BU patients?
The human pathogen Staphylococcus aureus is a notorious wound-colonizing bacterium. Therefore, 
the presence and genetic diversity of S. aureus in BU wounds was investigated. The results of 
this study are presented in Chapter 2. Using the bacterial typing method called multiple-locus 
variable number tandem repeat fingerprinting (MLVF), similar S. aureus genotypes were identified 
in samples from different Ghanaian out-patients, indicating possible transmission events during 
wound care. This suggests that effective infection control policies for wound care in health care 
centers in the respective BU endemic communities are either lacking or poorly implemented. 
This may be due to lack of trained healthcare personnel and poor resources for wound care. 
Furthermore, the results suggest that there may be interference in the healing process due to the 
presence of S. aureus and the S. aureus population dynamics as observed over time in the wounds 
of some BU patients. Of note, the study described in Chapter 2 was based on replica plating of 
used bandages and the isolation of different colonies of S. aureus from individual BU patients and 
particular wounds. This study therefore represents only a snapshot of the current situation and 
underappreciates the diversity of wound-colonizing bacteria and the dynamics in their presence. 
Future studies should try to define the dynamics more precisely with a focus on the entire BU 
wound microbiome over time and in relation to the therapy applied. This view is underpinned 
by the detection of both Gram-positive and Gram-negative bacteria in the investigated BU 
wounds. Furthermore, it will be important to confirm suspected transmission events using more 
discriminatory typing methods, such as whole genome sequencing (WGS). This will also improve 
our understanding of the antimicrobial resistance profiles of microorganisms responsible for 
wound colonization or infection and their possible impact on wound healing.
Is S. aureus transmitted during wound care of BU patients in health care centers? What are the 
implications?
The studies presented in Chapter 3 were performed to confirm S. aureus transmission events 
between BU patients during wound care as inferred from the studies presented in Chapter 2. 
To this end, a more discriminatory molecular typing method based on WGS was applied [1]. A 
phylogenetic analysis, based on a gene-by-gene analysis using the so- called SeqSphere+ software, 
identified two distinct S. aureus clusters that comprised the isolates involved in transmission 
events [2]. These findings are in line with the current view that WGS and subsequent phylogenetic 
analysis are the most appropriate tools for the assessment of transmission events, because they 
can confirm or reject cases that are suggested by conventional typing methods. However, there 
Discussion and Future Perspectives
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is a paucity of data from Africa where WGS analyses have little been used in tracking transmission 
events in healthcare settings [3]. Clearly, nosocomial events of transmission may impact heavily 
on morbidity and mortality rates in resource-limited settings. It would therefore be an asset  to 
implement WGS and phylogenetic analysis as part of the toolbox for laboratory diagnosis in the 
detection of transmission events in healthcare settings in Africa, especially when this technology 
becomes more affordable.
Another implication of the studies described in Chapter 3 is that further studies on bacterial 
transmission events in healthcare centers where BU patients are treated should include also the 
healthcare personnel, wound dressing materials and the applied equipment. This will help to 
pinpoint and eliminate the sources and modes of S. aureus transmission in health care settings in 
low resource settings.
Do S. aureus virulence factors potentially contribute to delayed wound healing in BU?
In Chapter 4, the virulence factors of S. aureus that potentially contribute to delay in wound 
healing of BU patients are discussed. These virulence factors are known to be involved in lysis of 
red blood cells, platelets, neutrophils, endothelial cells and the development of tissue necrosis. 
It is conceivable that tissue necrosis due to S. aureus continues after antimicrobial therapy to kill 
M. ulcerans. The results presented in Chapter 4 show that wounds of BU patients are colonized 
with S. aureus that carry various mobile genetic elements (MGEs) encoding known and potential 
virulence genes. Interestingly, several of these MGEs were identified for the first time and this was
especially the case for so-called Staphylococcal Pathogenicity Islands (SaPIs). Again, this focuses 
attention on the fact that there is currently too little information on the diversity  of S. aureus isolates 
from the African continent. To date, we do not know exactly how  the identified combinations 
of virulence factors impact on the virulence of the  investigated S. aureus wound isolates, but 
individual factors identified have been implicated in serious invasive infections. Further, it is 
conceivable that the MGEs identified can be transferred to other wound-resident staphylococci 
that can further prolong the duration of wound healing. In this context, it is noteworthy that in 
other wounds, such as diabetic ulcers where only S. aureus was found to colonize the investigated 
wounds, the virulence potential of certain identified S. aureus genes was associated with grade 
2-4 ulcers [4]. Therefore, further studies on possible correlations between the percentage change 
in wound size and the composition of the wound microbiome will probably give us a better 
insight how other bacteria together with S. aureus contribute to delayed wound healing in BU 
patients. In addition, in vivo animal experiments to determine the influence of particular virulence 
factors of S. aureus and/or other bacteria expressed during wound colonization may be of help in 
the selection of the optimal procedures for wound care.
How does S. aureus behave in wounds of Ghanaian patients with severe burns?
The World Health Organization (WHO) has described burns as the “forgotten global public health 
crisis”. World-wide, burns affect about 11 million people annually and they rank fourth amongst 
all injuries. Despite being a major cause of morbidity and mortality, especially in low- and middle-
income countries, the global impact of burn injuries remains unrecognised. Infection is one of the 
major causes of morbidity and mortality in burn patients. Nevertheless, at the start of this PhD 
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research project, precise microbiological data of the S. aureus prevalence in burn centers in Ghana 
were lacking. The studies described in Chapter 5 therefore addressed the epidemiology of S. aureus 
in a referral burn unit that receives burn cases from over 20 hospitals and the ICU of the respective 
hospitals. Almost half of the patients were colonized or infected with S. aureus including MRSA at 
the time of admission to the unit. This underpins the view that routine screening to detect MRSA 
colonization and infection in burn units in Ghana is necessary to minimize the number of days 
MRSA-positive patient are left unisolated and to  optimize antimicrobial treatment of infections. 
Furthermore, the predominant strains in the unit were MRSA that belonged to spa-type t928 
and multi-locus sequence type (ST250). These isolates were obtained both from patients and 
a healthcare worker, suggesting that there could be transmission events of MRSA occurring in 
the unit [5]. Interestingly, MRSA isolates from patients who were already colonized at the time 
of admission were part of the t928 cluster, which implies that MRSA surveillance could have 
prevented this MRSA transmission and outbreak in the unit. Despite the low socio- economic 
status of the burn patients, patients were further burdened financially on the choice of antibiotics 
for treatment of MRSA, in this case vancomycin. For instance, one gram of vancomycin costs 
$35. Sadly, the majority of the patients live below the minimum income of $1 per day and 
therefore cannot afford this treatment. The current situation is exacerbated by the tremendously 
high antimicrobial burden with mainly cephalosporines and aminoglycosides, which further 
contributes to the introduction and selection of multi-drug resistant microorganisms. Since 
antimicrobial resistant infections are likely to impact on the mortality rate in burn patients, it 
is concluded that future studies are necessary to obtain detailed information not only on the 
burden imposed by multi-drug resistant staphylococci, but also on the roles of Gram-negative 
bacteria, especially the notorious wound colonizer Pseudomonas aeruginosa. Of note, outbreaks 
of extended spectrum beta-lactamase (ESBL) producing Enterobacteriaceae have been reported 
in high-income countries where extensive infection preventive measures are practiced in 
healthcare settings [6]. Therefore, even higher numbers of thus far unnoticed outbreaks can 
be expected to occur in developing countries with limited resources. These could have a very 
high impact on patient mortality, especially in burn centers. Further studies should also address 
possible transmission events of Gram-negative bacteria, especially ESBL and Carbapenemase-
Producing Enterobacteriacae (CPE). This will give us a broader picture of the drug-resistant 
pathogenic bacteria that persist in the burn unit. ESBL screening of the patients’ environment 
including water, air, disinfectants, and visitors will enlighten us further on other transmission 
events and pathways in burn units.
Is MRSA surveillance in burn units of Ghanaian hospitals necessary? 
Most hospitals in Ghana do not perform active surveillance cultures. Rather, microbiological 
cultures are performed to detect MRSA based on worsening conditions of patients. Thus 
failure to identify colonized or infected patients and the resulting lack of contact isolation may 
result in increased rates of nosocomial MRSA infection. In  Chapter 6, phylogenetic analyses of 
available sequence data and epidemiological analyses to confirm MRSA transmission events in 
the burn unit were performed. The results imply that, indeed, Ghanaian burn units are high-risk 
settings for nosocomial transmission of MRSA. In addition to confirming transmission events, 
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the phylogenetic analyses further identified multiple patients who acted as the index source of 
transmission to other patients. Here, multiple isolates from single patients sampled at the same 
time or at different time points were shown to serve as a source of transmission to other patients 
[7]. Epidemiological data showed an overlap of some patients’ stay and the possible involvement 
of a healthcare worker in the transmission pathway [8]. With the other patients whose stays did not 
overlap, it is perceived that the observed transmission may have occurred through contaminated 
surfaces such as beds, wound care equipments or the surrounding environment in the respective 
wards [9,10]. To minimize MRSA transmission, patients colonized or infected with MRSA should 
therefore be isolated.
In conclusion, antimicrobial resistance is a major problem in low-income countries, such as Ghana. 
The implementation of antimicrobial stewardship would probably be the most effective way to 
limit the spread of infections by antimicrobial resistant pathogens and to reduce the morbidity 
and mortality amongst frail patients. Unfortunately, the financial resources and logistics to support 
routine laboratory diagnosis as well as skilled personnel to perform and analyze WGS data are 
currently lacking in hospitals in resource-limited countries, such as Ghana. Such discriminatory 
methods would however help to identify thus far unnoticed outbreaks, to confirm suspected 
MRSA transmission events, and to help prevent these outbreaks in healthcare settings. Clearly, it 
would not be sensible to wait with the implementation of more effective measures for infection 
prevention and antimicrobial stewardship until WGS becomes more affordable. Instead, it will be
important to systematically implement cheap and readily available screening methods with high 
discriminatory power to eliminate possible sources of bacterial transmission. For example, this can 
be achieved by a combination of MLVF and spa-typing for the initial screening of patient isolates, 
as has been described in this PhD thesis. In addition, careful training of healthcare personnel in 
matters of hygiene, infection control and wound care will help to enhance wound healing and to 
limit the risks of infections by highly drug-resistant microorganisms.
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